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INTRODUCTION 
 
The Safe Medicine Disposal for ME (SMDME) program is a statewide model for the 
disposal of unused household medications using a mail-back return envelope system.  
Established through state legislation and implemented in 2007 with a grant from the 
U.S. Environmental Protection Program’s Aging Initiative, the program is authorized to 
handle both controlled and non-controlled medications (see appendix group 4 for 
historical documents related to the program). This handbook describes the program 
components, as well as the outcomes and lessons learned from Phases I & II of the 
program.  The handbook is designed as a guide to organizations that are implementing 
similar programs in other states. 
 
Maine, which has a combination of rural regions and urban centers, serves as an ideal 
state in which to test distribution and collection methods, combined with cost 
containment. The pilot program began with 11 participating pharmacies, and has since 
expanded to include approximately 150 pharmacies and health and human services 
agencies in all 16 counties of Maine. The program has broadened from the original 
target audience of older adults and caregivers to include adults of all ages. The program 
currently maintains a waiting list of interested community-based distribution sites.  
 
The mail-back program, during its first two phases of operation, has disposed of more 
than 2,300 lbs of drugs, representing 3,926 envelopes.  Pharmacist and pharmacy tech 
volunteers have cataloged and inventoried those envelopes through eight cataloging 
events during the first two phases of the program.  The volume was so great that the 
inventory method was changed to a 20% sampling process during the second year of 
operation. 
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Why Collect Unused Pharmaceuticals? 
 
The Athens Declaration,1 developed in 2007 at the 2nd International Conference on the 
Environment in Athens, Greece, supported six reasons for citizens to tackle unused 
drug disposal:  (1) to curtail childhood overdoses; (2) to restrict household drug theft; (3) 
to limit accumulation of drugs by the elderly; (4) to protect our physical environment; (5) 
to restrain improper international drug donations; and (6) to eliminate waste in the 
international health care systems of all 
countries. 
 
Any or all of the Athens Declaration reasons 
could be adopted as program goals for a 
mail-back drug return program.  Goals 
should state in general terms what the 
program aims are, and what impact you 
hope to have.  The Athens Declaration 
components describe a hoped-for result, 
but state it in a general (not objectified) 
fashion. 
 
 
The Pharmaceutical Manufacturers’ Association estimates that more than 3.6 billion 
prescriptions are written each year in the United States.2 More recent figures indicate 
that U.S. sales of prescription medicines rose 5.1 percent in 2009 to $300.3 billion.3 In 
Maine, more than 16 million prescriptions were filled in 2008,4  including 2.3 million 
                                             
1 The Athens Declaration can be found at http://www.mainebenzo.org/athensdeclaration.htm.  The Declaration refers 
to two World Health Organization documents, the WHO Guidelines on Drug Donations and the WHO Guidelines on 
Drug Disposal, which are also referenced at this web address. 
2 Pharmaceutical Manufacturers Association, Frequently Asked Questions, accessed December 21, 2009, 
(http://www.phrma.org/frequently_asked_questions) 
3 The Star-Ledger, Prescription drug sales rise 5.1 percent in 2009, accessed April 2, 2010, 
(http://www.nj.com/business/index.ssf/2010/04/prescription_drug_sales_rise_5.html) 
4 United States: Prescription Drugs, Compare United States to Maine, accessed December 21, 2009 
(http://www.statehealthfacts.org/profileind.jsp?cmprgn=21&cat+5&rgn=1&sub=66) 
 
The Athens Declaration 
(see appendix) 
 
Rationale for citizen unused drug disposal 
 
• To curtail childhood overdoses 
• To restrict household drug theft 
• To limit accumulation of drugs by the 
elderly 
• To protect our physical environment 
• To restrain improper international 
drug donations 
• To eliminate waste in the international 
health care systems of all countries 
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prescriptions for controlled drugs,5 or 157 million dosage units. Yet, research indicates 
that patients very frequently do not take prescribed medications as they were directed, if 
at all.6,7  
 
 
 
 
 
In Maine, diverted, abused, and misused prescription drugs are a major cause of 
accidental poisonings and arrests.  In 2008, 95% of Maine drug deaths were caused 
by pharmaceutical drugs, either alone or in combination with other drugs.8 The state 
has seen arrest rates for prescription drug-related offenses rise from 50 in 1998 to 75 in 
2003, and 259 (39% of all arrests) in 2008.9  According to data from the 2008 National 
Drug Intelligence Center’s National Drug Threat Survey, the state of Maine ranks 
number one in the country in terms of the perceived relationship of pharmaceuticals to 
violent crime and property crime, and second in terms of the availability of 
pharmaceuticals for abuse. Forty percent of Maine law enforcement agencies perceive 
prescription drug misuse as the most serious drug threat.10    
 
Medication safety affects all ages. For youth, one of the fastest growing trends 
nationally in teenage prescription drug abuse is the “pharm party” where teens dump 
bottles of prescription medications they have found into a punch bowl to be distributed 
like candy.  According to results from the 2006 Maine Youth Drug and Alcohol Use 
(MYDAUS) Survey, 12% of teenagers in grades 6 through 12 across the state report 
                                             
5 Maine Prescription Monitoring Program, “PMP Prescription Count Trends within Counties,” 
(http:///www.maine.gov/dhhs/osa/data/pmp/reports.htm), accessed December 21, 2009. 
6 Sabate, E. (ed.) Adherence to Long Term Therapies: Evidence for Action.  World Health Organization.  Geneva, 
2003. 
7 Osterberg, L and T. Blaschke, “Adherence to medication,” New England Journal of Medicine 353:487-97, 2005. 
8 Personal communication, MH Sorg, Rural Drug and Alcohol Research Program, Margaret Chase Smith Policy Center, 
University of Maine. 
9 Sorg, MH (forthcoming) Patterns and Trends of Drug Abuse in Maine.  In Epidemiologic Trends in Drug Abuse: 
Proceedings of the Community Epidemiology Work Group, June 2009. National Institute on Drug Abuse. 
10 Testimony presented at the Hearing on HP0557, LD 821, An Act To Support Collection and Proper Disposal of 
Unwanted Drugs, April 14, 2009. 
 
Yet, research indicates that patients very frequently do not take 
prescribed medications as they were directed, if at all. 
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experimenting with prescription drugs, and 1 in 5 Maine youth in grades 9-12 report 
having used a prescription drug not prescribed to them to get high.  
 
For older adults, persons 65 and older represent 13% of the U.S. population yet 
consume about a third of prescriptions sold.11 Older patients also have the lowest 
prescription drug compliance rates of any age, including never filling their prescription, 
filling but not taking the prescription, taking only part of the doses, or taking less than 
the prescribed dose.12 These behaviors occur in all age groups, not just elders, and 
result in an accumulation of medications in the household. 
 
The large, accumulating volume of unused pharmaceuticals not only poses potential 
dangers to communities and to the environment,13 it also represents a significant over-
expenditure of health care dollars.  Pharmaceutical drug residues have been found in 
many environmental contexts, including our sewer systems and our drinking water.14 In 
a recent study by the Maine Department of Environmental Protection (MDEP), 
pharmaceuticals and personal care products (PPCPs) were found in 18 out of 19 
samples of Maine water samples,15 with a majority of sites having three or more types of 
PPCPs present. 
 
Although research clearly shows the presence of pharmaceuticals and other personal 
care products in our water supply, the effects of these exposures on the environment 
will depend on many factors, including the specific chemicals involved and the variation 
in their effects on different organisms.  One topic that is of concern to some scientists is 
the impact on reproduction processes.   
                                             
11 Prescription Drug Abuse Statistics. www.prescriptiondrugabuse.us/statistics-facts.html, accessed December 21, 
2009. 
12 Kocurek, B., “Promoting medication adherence in older adults…and the rest of us. Diabetes Spectrum 22:80-84, 
2008. 
13 Daughton, C. “Drug disposal: Ramifications for the environment and human health.” U.S. Environmental Protection 
Agency, Drug Disposal, Pharmaceutical and Personal Care Products. 
(http://www.epa.gov/ppcp/projects/disposal.html), accessed December 21, 2009. 
14 Ruhoy, I.S. and C.G. Daughton, “Types and quantities of leftover drugs entering the environment via disposal to 
Sewage-Revealed by coroner records,” Sci. Total Environ. 388(1-3):137-148, 2007, also available at 
(http://www.epa.gov/newlesd1/bios/daughton/SOTE2007.pdf) 
 
15 Littell, D.P. (2007) “Waste Pharmaceuticals: The Road Forward,” Maine DEP.  Conference Presentation, Improving 
Patient Safety through Informed Medication Prescribing and Disposal Practices, Fourth Annual Unused Drug Return 
Conference, (http://www.mainebenzo.org/documents/WastePharmaceuticalOct07_001.pdf). 
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More research is needed to clarify both the short term and long term impacts on 
humans.  In addition, research is needed to document the costs and benefits of various 
interventions.  This project contributes to the ongoing discussion. 
What Is The Best Way To Dispose Of Medicines? 
 
Several basic methods are currently being used in the United States to dispose of 
unused medicines:  flushing, throwing away and collecting.  These approaches are 
reviewed in the Appendix in a document prepared by the Northern New England Poison 
Center (see the Medication Disposal Summary Report in Appendix Group 4).  Opinions 
about the best method for drug disposal vary widely.  Benefits and costs of each 
method are different, and state legislatures have addressed these issues in different 
ways.  The most important goals that concerned citizens and legislatures focus on are 
(1) preventing poisoning, (2) preventing drug abuse, (3) ensuring the safety of patients, 
and (4) limiting environmental impacts. 
 
The method described in this handbook 
involves a statewide effort to collect drugs 
using a mail-back system, followed by high 
temperature incineration. This method has 
the advantages of preventing unintentional 
poisonings, preventing access to medicines 
by drug abusers, and limiting impact on the 
environment.  It is not as immediately inexpensive to the community, or as convenient, 
as throwing away or flushing.  However, throwing away and flushing may create long 
term environmental costs that communities may have to bear in the future. 
 
The mail-back mechanism has the advantage of being continuously available to 
community members.  Compared to event-type community take-backs, the mail-back 
program does not contribute to hording medicines between take-back events, which 
might set the stage for diversion or poisonings. 
Medication Disposal Goals 
1. Prevent poisoning 
2. Prevent drug diversion & 
abuse 
3. Ensure patient safety 
4. Limit environmental 
damage 
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Mail-back programs incur immediate costs, involve substantial program management, 
and still require law enforcement collaboration as do other models.  These costs should 
be balanced against the estimated costs of future environmental damage, as well as the 
societal costs of drug diversion and poisoning. 
 
An additional cost factor to consider is the drug waste within our medical system.  
Medication accumulates in households because too much, or the wrong drug was 
prescribed; patients did not take the drugs, or did not take them as directed.  These 
effects point to the importance of careful prescription management and patient 
education at the front end.  
How to Use This Handbook 
 
This handbook was produced as a general guide to organizations interested in 
developing a mail-back program in their state, region, corporate or affinity group.  It is 
not meant as a step-by-step manual.  Each state’s laws and cultural context are unique.  
For example, responses and participation by particular stakeholders, such as law 
enforcement agencies, will vary greatly.  Additionally, ideas about prescription drug 
return programs will have evolved since work began on this project two years ago.  
There must be recognition that Federal law and regulations has played a major role in 
shaping, and at times constraining, certain aspects of the mailback program design.  
 
Thus, we have provided an overview of the principles and guidelines to serve as a 
concept umbrella. Readers will find more specific material in the appendices.  These 
documents may be of assistance as new programs are developed and the guidelines 
are being implemented.   
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Helpful Appendices Included:
• Contact information for program leadership 
• Organizations (state, federal, national, and international) that were involved, to 
provide ideas about stakeholders to include 
• A detailed project conceptual timeline to assist in planning 
• Legal and technical documents and agreements that link the project with 
multiple stakeholders 
• Sample distribution site materials 
• Helpline and volunteer information 
• Instruction booklet for preparing and returning medicine 
• Marketing and outreach materials 
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BUILDING A SOLID FOUNDATION 
 
 
 
 
 
 
 
 
 
 
 
 
 
Engaging Stakeholders: Community, Academic, and Government 
 
By the time the proposal to pilot the Maine mail-back program was written in 2007, a 
wide range of stakeholders had been engaged for several years in discussions with 
policy makers about Maine’s prescription drug problem generally.  A coalition, initially 
convened by the Maine Benzodiazepine Study Group (MBSG) and the Maine Drug 
Enforcement Agency (MDEA), began to consider drug return programs as one solution 
beginning in 2002.   
 
Stakeholders were included in these discussions from children’s advocacy, substance 
abuse treatment, law enforcement, environmental organizations, medical associations, 
university research programs, as well as legislators and other policy makers.  Every 
effort was made to come to informal consensus as the work proceeded. Communication 
with Federal agencies was initiated early on in the process for general guidance and to 
ensure clarification of existing regulations.  
 
 
“A major reason we went with a mail‐back program is that we’re the third 
most rural state in the nation, our population is very dispersed, and we have 
a significant prescription drug problem. We believed mail‐back 
programming might be the most convenient and the least cumbersome 
method to use. We not only considered rurality issues, but also considered 
the vulnerability of populations who are less mobile, and less physically able 
to transport medications from one point to another.”  
Lenard Kaye, D.S.W, Ph.D, Director and Professor, 
        University of Maine Center on Aging 
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Detailed discussions and presentations of research clarified the costs and benefits of 
various drug disposal approaches that had been tried, and highlighted some of the 
program issues to be faced by the Maine program.  These efforts ultimately stimulated 
the passage by State Legislation of Public Law 2003, Chapter 679, which formed the 
Maine Unused Pharmaceutical Disposal Program, and created the Maine Drug Return 
Implementation Group.  This work group came to consensus that a mail-back approach 
would work best in Maine.   
Meeting the Challenges of a Rural and Aging State 
 
Maine ranks 38th in population density nationwide with fewer than 10 residents per 
square mile in over half of the state.  This poses challenges to distribution and collection 
methods as well as financial challenges. Maine also has the oldest population in the 
country with a median age of 41.2 years (United States Census, 2005).  Needing to 
travel long distances to bring unused drugs to a collection site would have posed 
problems for a substantial number of Maine’s elders.  Using the U.S. Postal Service 
system solves that problem because virtually all of Maine’s citizens have access to the 
mail. 
Selecting an Environmentally Sound and Legally Secure System 
 
In addition to the issues involved in securing and transporting drugs over long 
distances, there was controversy about the best way to dispose of them. Program 
leaders were aware of the research about the environmental hazards posed by drugs 
getting into the groundwater, either through flushing or solid waste disposal.  Although 
the financial costs and impact on air quality were also certainly important factors, 
incineration was ultimately chosen as the method of disposal for the mailback program 
as it would minimize environmental impact. All drugs collected undergo high-heat 
incineration, according to the procedure already established for Maine’s law 
enforcement drug seizures. 
 
Incineration avoids the problems of direct contamination of water.  The MDEA had been 
using this method to dispose of drugs from law enforcement seizures.  The form of 
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incineration already in use by the MDEA was a controlled, high-heat process designed 
to convert waste to energy. (See Appendix 4E for a breakdown of other drug collection 
methods with their advantages and disadvantages.) 
Political Will and Partnerships 
 
Issues surrounding the collection and disposal of pharmaceuticals involve many 
professional, legal, and regulatory agencies.  For this reason any proposed project 
should be founded upon an extensive network of professional and community 
partnerships.  Development of these working relationships took several years prior to 
actual implementation of the Maine program and involved each of those acknowledged 
at the beginning of this handbook.   
 
Key project partners within Maine included the Maine Benzodiazepine Study Group, the 
Maine Department of Environmental Protection, the Maine Drug Enforcement Agency, 
the Maine Office of Substance Abuse, the Maine Department of Health, the Maine 
Office of the Attorney General, the U.S. District Attorney for Maine, and the University of 
Maine Center on Aging. A technical expert advisory task force was formed that included 
members from each of these and a cadre of partnering organizations.  The Community 
Advisory Group (explained in more detail later) provided a critical consumer 
perspective, including the perspectives of individuals involved “at the front line:” the 
project volunteers handling community education and marketing. 
 
The Maine Department of Health and Human Services and the Maine Department of 
Environmental Protection both provided assistance with public education and outreach 
in Phase I and II, and a representative from each group acted as their organization’s 
liaison to the project. 
 
A number of state and national specialists and associations also committed to the 
project.  Both the Community Medical Foundation for Patient Safety and the National 
Council on Patient Information and Education agreed to enlist their staff to review 
instructions and informational materials to be distributed to distributions sites and mail-
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back participants. Rite Aid Corporation, the nation’s third largest drugstore chain and 
the largest on the east coast, formally committed to participation in the pilot project with 
their pharmacies serving as distribution site locations. 
 
Researchers from the University of Maine Margaret Chase Smith Policy Center 
committed to project evaluation and to act as an outside advisor to the project on 
matters related to drug disposal.  
 
In Maine, there has also been a key legislative component to coalition building. In 2003, 
the Maine Benzodiazepine Study Group and the Maine Drug Enforcement Agency 
convened a group of stakeholders from various sectors and professions including 
children’s advocacy, environmental and medical organizations, and higher education 
research units. The Center on Aging at the University of Maine assumed the 
administrative coordination of the project.  The group’s focus was to create legislative 
solutions to the problem of diversion, misuse and abuse of prescription drug 
medications.   
 
A legislative mandate, Public Law 2003, Chapter 679,16 created the Maine Unused 
Pharmaceutical Disposal Program and tasked the Maine Drug Enforcement Agency 
with the program’s administration.  The Maine Drug Return Implementation Group was 
also formed.  This group was tasked with addressing postal regulations, methods and 
requirements for mailing, minimizing drug diversion and theft of mailed returns, 
providing public education, and encouraging the development of turn-in programs.  This 
mandate encouraged the implementation group to seek outside funds.  A grant proposal 
was made to the U.S. EPA Aging Initiative to pilot the program (findings and activities 
covered in this report).  
In 2007, the Maine Legislature enacted Maine LD 411  “An Act to Establish a Pilot 
Program for the Return of Unused Prescription Drugs by Mail.” This initiative provided 
                                             
16 See http://www.mainelegislature.org/ros/LOM/LOM121st/15Pub651-700/Pub651-700-
126.htm#P9390_1232537 
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an additional $150,000 to the pilot which allows the program to continue for an 
additional two years beyond the initial EPA grant.  
Partnering with Law Enforcement is a Key Component 
 
Close partnership with the Maine Drug Enforcement Agency (MDEA) provided the 
critical involvement of law enforcement.  By law, only law enforcement entities are 
permitted to receive and handle returned pharmaceutical drugs classified as Schedules 
II, III, and IV, which includes narcotic analgesics, sedatives, and stimulants.17 Their 
involvement is necessary to insure security, to prevent drug diversion, and because the 
law requires it. Because of the likelihood that controlled substances would be an 
important subset of the returned drugs, the MDEA agreed to oversee receipt of drugs 
returned via this program.  
 
Maine’s mail-back program also required partnership with the MDEA in order to facilitate 
use of the already-established incineration disposal method, as well as to actually 
transfer the returned drugs for incineration.   
Selecting a Central Coordinating Agency 
 
From this base, the University of Maine Center on Aging (CoA) took the leadership role 
in seeking funding for a pilot study from the U.S. Environmental Protection Agency’s 
Aging Initiative.  The Center on Aging has a number of characteristics that were 
advantageous for this role.  First, as a department within the University, the Center is a 
qualified non-profit organization and therefore able to receive federal funding.  The CoA 
has the institutional base to act as the fiscal and administrative agent for what was to 
become a highly visible and complex project.  This includes qualified personnel, 
experience with community/academic/government partnerships, and accessible, 
centrally-located headquarters that can house meetings and coordinate 
communications. 
 
                                             
17 DEA Schedule of Controlled Drugs, http://www.justice.gov/dea/pubs/csa.html 
Safe Medicine Disposal for ME: A Handbook and Summary Report  ? April 2010 18 
 
In addition, the CoA is well-known statewide and trusted by communities and elder 
networks.  They have established communication vehicles (website, newsletter, on-
going functions) to facilitate the education and marketing so essential for an innovative 
project.  The social network qualifications of the CoA proved to be beneficial during all 
phases of the project. 
Developing Organization Capacity 
 
The following sections of this report provide some basic guidelines in developing 
organizational capacity to address the problem of unused pharmaceuticals.  If you are 
just starting a program it is important to refine your organization’s intentions and clarify 
how you wish to proceed.  In other words, agreeing on a mission, goals, and objectives.  
This is a necessary step not only in focusing your organization’s resources, but also a 
requirement in order to seek external funding.  
 
Each organization will be different.  For that reason, we begin each of the following 
three sections with basic instructions that can be applied broadly.  We then use our 
program as a specific example. 
Developing a Program Mission 
 
This first step focuses on your organization’s values with respect to the problem or set 
of problems confronting your community.  The mission statement should express what 
you want your organization to be in relationship to that problem?   
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You might begin by constructing the following: “We are [insert a phrase that describes 
who you are as a group] who agree on the importance of [insert value/values] in 
addressing [insert problem you want to solve], we will [insert what you have agreed to 
do about it].  After you decide on these components, you can edit the statement to make 
it flow better, for example:  As an academic-community partnership concerned with the 
environmental risks posed by the accumulation of unused household pharmaceuticals, 
we work together enthusiastically to support and implement a successful mail-back 
program. 
Goals, Objectives and Outcomes 
 
Deciding on goals, objectives, and outcomes will help your organization do more 
effective planning and implementation. Articulation of these program components is 
usually required by funding agencies.  Check carefully with the agency funding 
announcements, however, because agencies may differ in exactly how they define 
these terms.   
 
Goals are the general targets your program will aim for, usually phrased as some sort of 
societal improvement.  Setting goals is similar to setting a navigation course by pointing 
your sights toward a star or a distant land mass.  Goal statements can then be clarified 
by defining and discussing concepts and terms used in the goal statements. 
 
In contrast, objectives are specific, observable accomplishments that demonstrate 
progress toward the program goals, or even define ultimate goal achievement.  
Objectives can be mid-range or long-range.  They can function as benchmarks or 
Sample Mission: 
As an academic‐community partnership concerned with the environmental risks posed by 
the accumulation of unused household pharmaceuticals, we work together enthusiastically 
to support and implement a successful mail‐back program. 
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milestones, signals along the way that let you know your efforts are successful as you 
move toward a goal. Or, long term objectives can be used to operationalize success in 
arriving at the program goal.  
 
Objectives should be indicators that can be agreed upon, even by an observer or 
evaluator outside your organization. Objectives are useful for planning; they constitute 
the day-to-day things the organization must actually mobilize itself to do.  They should 
be phrased in such a way that an administrator can use them in order to make decisions 
about how to direct resources and personnel. 
Maine’s Goals and Objectives 
 
The goals for a prescription drug 
return program in Maine, were 
two-fold: 1) to devise, implement 
and evaluate a mail-back plan to 
remove unused and unwanted 
medications, both prescription and 
over-the-counter, from residences 
and dispose of them in compliance 
with applicable state and federal laws and sound environmental practices, and 2) to test 
the effectiveness of an educational campaign about the hazards to life, health, and the 
environment posed by improper storage and disposal of unwanted medications. A cost-
effective model for the disposal of unwanted medication would be created and 
implemented, and an educational campaign would be instituted in each of Maine’s 16 
counties. Further, the project would address potential barriers to participation due to 
age, infirmity, rural locale, and other challenges. 
 
Maine’s Goals 
1. To devise, implement and evaluate a mail‐
back model 
2. To test effectiveness of an educational 
campaign about risks of improper storage 
and disposal 
3. Develop a framework for a national model 
and ensure replicability 
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Maine developed a list of 15 milestones and completion dates, which functioned in 
effect as intermediate program objectives.  These included first a model development 
phase:  (1) develop consolidation, transportation, and incineration protocols; (2) contract 
with incineration facilities and transportation vendors; (3) commence meetings of 
technical advisor task force;  (4) secure network of 75 mailer distribution points 
(pharmacies); (5) engage community advisory board and commence meetings; (6) 
design and produce mailers, mailer survey, training materials for distribution site 
educators, and instructions for pharmacies and the public; (7) create web site and 
establish a toll-free helpline and helpline training 
materials; (8) engage and train distribution site 
educators; (9) develop public education campaign 
content and dissemination plan. 
 
The implementation included a Phase I to pilot the 
program components, specifically: (1) launch Phase 
I education campaign; (2) distribute informational 
materials and provide training for pharmacists, staff, 
and individuals acquiring mailers; (3) collect, 
inventory, and destroy returned products from 
Phase I locations in compliance with applicable 
state and federal laws and sound environmental 
practices statewide; and (4) evaluate Phase I and 
refine for Phase II. Phase I program components 
were implemented and designed to specifically 
target older adults and caregivers. 
 
Objective milestones for Phase II included: (1) 
distribute informational materials and provide 
training for pharmacists, staff, and individuals acquiring mailers for Phase II; (2) collect, 
inventory and destroy returned products; (3) generate, analyze and report on survey 
and inventory data in a manner that allows physicians, pharmacists, insurance 
companies, patients, and others to modify behaviors to minimize unused medications; 
Nuts & Bolts 
 
Mission 
Develop a program mission that 
expresses in simple terms what 
you want your organization to be. 
 
Goals 
Decide on program goals that 
express what you want your 
program to aim for in its work 
overall. 
 
Objectives 
Define medium‐term and longer‐
term objectives, that is, clear 
benchmarks that need to be 
accomplished along the way in 
order to demonstrate you are 
achieving your goals. 
 
Outcomes 
Describe the measureable 
outcomes that will result if you 
have met your goals. 
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(4) evaluate need for Phase III (and institute as necessary); (5) conduct final evaluation; 
and (6) publish best practices handbook.  It is important to note that Phase II expanded 
the program exposure to population groups beyond older adults.  
 
Maine’s long term program objectives included: 1) calculating the weight, type and 
hazardous characteristics of returned medications by actual pill count and drug 
classification; 2) calculating the cost of the mail-back program as a model for future use 
nationally, by other organizations and states; and 3) offering a statewide education 
campaign targeted toward the proper use and disposal of prescription drugs with an 
initial focus on citizens 65 and older. 
 
Projected outcomes included: 1) understanding the practicality and costs associated 
with a mail back medication return program; 2) information on the best methods to 
educate older adults concerning the hazards of unused medications and improper 
disposal; 3) reduction in the amount of medications available for improper disposal, 
diversion or poisoning; and 4) heightened awareness by the public-at-large and older 
adults in particular that could lead to a reduction in accidental deaths, human and 
animal poisonings, and suicides caused by unused medications.  
 
 
 
 
 
 
 
 
 
Maine’s Expected Outcomes 
1. An understanding of the model’s practicality and costs 
2. Information on best methods to educate older adults about hazards of unused 
and improperly disposed medications 
3. A reduction in the medications in Maine available for improper disposal, 
diversion or poisoning 
4. Heightened public awareness, especially in older adults, of the risks caused by 
accumulated or improperly disposed medications 
Maine’s Long Term Program Objectives 
1. Conduct a statewide educational campaign on proper use and disposal 
2. Calculate weight, type, and hazardous characteristics of returned medication 
3. Calculate the cost of the mail‐back program model
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THE BASICS OF THE PROGRAM 
 
 Why Maine Mailback Participants Use the Program 
 
Findings from program participant surveys from the Maine SMDME program itemized 
multiple reasons for drug accumulation in their homes, including:  
• Medicine belonged to a deceased family member (19.6%) 
• A physician told the patient to stop taking the medication or gave the patient a 
new prescription (27.3%) 
• The person had a negative reaction or allergy to the medicine (11.9%) 
• The person felt better or no longer needed the medicine (18%) 
 
Participants also noted multiple reasons for removing the drugs from their homes, 
including concerns for the environment, drug compliance, drug safety, as well as for 
preventing drug diversion.  Some noted they did not want anyone else to use the 
medicine.  Some were concerned about the potential poisoning dangers to children, or 
the risks of drug abuse diversion.  Often the medicine was expired or outdated and no 
longer useful.  In some cases this adds to their potential for misuse or harm.  
Figure 1.  Motivation for Using the Mailback Program 
Motivation for Using the Mailback Program
N = 1828
77%
16%
4% 3% Best for theenvironment
Safest for me and
my family
Free to use
Most convenient
 
Nearly half (46%) of those surveyed reported that, in the absence of a take back 
program, they would have flushed drugs down the toilet.  Another one third (37%) would 
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have dumped left over prescriptions into their trash. These disposal solutions can pose 
environmental risks.  Overwhelmingly, 77% of program survey respondents cited 
participation because, “it’s best for the environment.” 
 
 
 
 
 
Refining the Concept: The Mail-Back Model 
 
There are five primary models for drug take-back programs. The first, a pharmacy-
based take back program, which is considered to be a controversial approach 
nationally.  Because returned medications often include Schedules II, III, and IV drugs, 
which have a higher abuse potential, the DEA regulations require that they be received 
and transported by law enforcement personnel. 
 
In-person event-driven take back programs, the second model, are coordinated locally 
(community-by-community) and would take the commitment of multiple police 
departments and multiple law enforcement agencies to enact a statewide program. 
Such events are offered sporadically and rely on local law enforcement to shoulder the 
time commitment and costs associated with take back programming.  
 
The third and fourth models, police department drop-off and pick-up, are emerging 
models that have been developed through local community policing efforts. Both models 
are not yet widely available but continue to grow in popularity in local communities. 
 
The fifth model, a statewide mail-back prescription return program, was most 
appropriate for Maine.  It allows drugs to be returned directly to one agency, which 
reduces coordination costs.  In Maine, the Maine Drug Enforcement Agency (MDEA) 
has statewide jurisdiction and had been involved in concept development.  It was 
therefore the most appropriate for piloting in Maine.  The statewide mail-back model 
Overwhelmingly, 77% of program survey respondents cited 
participation because, “it’s best for the environment.” 
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offers a centralized coordination component, adds an element of confidentiality and 
anonymity not found with in-person take back programs, and is the least burdensome of 
all models in terms of consumer participation (see Appendix 4E for a comprehensive 
review of various models). 
 
 
 
 
 
 
 
 
 
Figure 2.  Center on Aging staff member orients a participating pharmacist to the program 
 
 
Tasks Leading Up to the Actual Mailback 
 
Before a mailback can begin, there are a number of preliminary tasks that must be 
accomplished. In Maine, this included the following (see Appendix 3 for complete 
timeline):  
• Create consolidation, transportation, and incineration protocols 
• Contract with incineration facilities and transportation contractors 
• Commence meetings of technical advisory task force 
• Secure network of distribution points (pharmacies, community sites, etc.) to 
which mailers are distributed in both phases  
The statewide mail-back model offers centralized coordination…, adds 
…confidentiality…, and is the least burdensome of all models in terms of consumer 
participation. 
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• Engage community advisory board members 
• Commence meetings of community advisory board 
• Design and create mailers and accompanying survey, training materials for 
Distribution Site Educators and instructions for 
pharmacies and public 
• Create web site, establish 800 number call center 
and create related training materials and protocols 
• Engage and train Distribution Site Educators 
• Develop education campaign content and 
communication dissemination plan 
• Launch Phase I education campaign 
• Distribute informational materials for pharmacists, 
staff, and individuals acquiring mailers for Phase I; 
provide training 
 
The Bottom Line: Costs and Funding 
 
Below is the actual phase I and II budget for the Maine program. As noted, the per- 
envelope cost in the initial years of the program is significant given the staff time and 
effort needed to create a novel program. Additionally, the value of donated time from 
pharmacists and pharmacy tech staff totaled approximately $800 for each inventory 
event toward the end of the project period.  The time and effort contributed by 
Community Educator volunteers was calculated to be $20.25/hour as estimated by the 
Independent Sector.18 
 
 
                                             
18 www.independentsector.org 
Figure 3. Each pharmacy 
receives a program sign to 
market the availability of 
envelopes 
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Now that piloting has been completed for the program, the administrative costs for the 
program have been reduced considerably. Below is the currently two-year operational 
budget for the mailback program which includes enough funding to distribute and 
process 20,000 mailback envelopes from across the state.  
 
Phase I and II Actual Program Costs 
(9,400 envelopes, 42% return rate)
Budget Line Actual Cost
Envelopes (including freight); supplies and materials $6,214.38
Assembly and printing (assumes color printing and survey printing and assembly) $9,358.62
Postage including PO Box permit $11,310.22
Disposal for both controlled and non-controlled drugs (2,123 pounds non-controlled and 250 
lbs controlled) $7,111.00
DEA staff costs, data analysis consultants, research consultants $21,402.13
Website and Phone costs (User support) $4,237.53
Travel for cataloging/research activities/program administration $4,000.00
Staff time-program administration $50,002.12
Subtotal $113,636.00
Indirect Costs: Facilities, grant and contract administration, etc. $36,364.00
Total cost: $150,000.00
Per unit cost: $15.96
In-kind provided to the project in Phases I and II $26,607.13
Per unit cost factoring both actual costs and in-kind provided $18.79
In-kind detail: 9,000 mailers donated by Polyair Manufacturing: $2,394.63; Time and 
effort donated by Principal Investigator: $11,130; Pharmacist and pharmacy staff 
donated time: $6,400; Community Educator volunteers (330 hours x $20.25 per hour 
value): $6,682.50  
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Phase III Two-Year Budget
Base of 20,000 envelopes, 30% return rate assumption
Envelopes (including freight) $6,200
Assembly and printing (assumes color printing and survey printing and assembly) $12,000
Postage ($2.50 average per returned envelope) $15,150
Postage Fees (permit and PO Box for one year) $1,850
Disposal $16,000
DEA staff costs $10,200
Cataloging, data entry, data cleaning, reporting (pharmacist time, data entry staffing) $12,000
General supplies $3,800
Website and phone costs (User support) $2,805
Travel for cataloging/research activities/program administration $3,000
Staff time-program administration (40%FTE) $47,506
Volunteers (training, travel, support costs) $2,000
Subtotal $132,511
Indirect costs (13.4%) charged on all direct costs except volunteer/participant support $17,489
Total cost: $150,000
Per unit cost: $7.50
* budget assumes 30% return rate after Phases I & II  
 
Implementation Structure 
 
The Safe Medicine Disposal for ME mail-back model was conceived in two phases and 
has since moved into a third phase:  
Phase I Overview: In this pilot program, 1,800 postage-paid, padded mailers were 
made available to consumers at 11 pre-selected pharmacies in four Maine counties 
(see Figure 4). Counties were selected for their geographic disparity, access to rural 
and urban communities, and demographic characteristics of residents (age, 
socioeconomics, education, culture, lifestyle, etc.). This initial phase allowed staff to 
monitor the program, pilot protocols, and revise as needed before Phase II 
implementation went statewide.  Phase I did not include marketing strategies or a 
public education component, and there was limited press coverage of the program.  
Only persons aged 65 or older and their caregivers were encouraged to participate.  
Phase II Overview:  Safe Medicine Disposal for ME went statewide in Phase II with 
7,600 mailers available in all 16 Maine counties (see Figure 4). Initial envelope 
distributions to sites during this phase were based on county population size. 
Pharmacies continued to be the primary point of distribution for program envelopes, 
although site selection expanded to include health agencies, doctors’ offices, social 
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service programs, and Area Agencies on Aging.  This phase included a public 
education component with extensive, targeted marketing urging individuals into 
distribution centers for the purpose of picking up and using return mailers. All age 
groups and caregivers were eligible to participate in the program.  
Phase III Overview:  During Phase III the program was expanded to additional sites 
within the state’s 16 counties (see Figure 5).  The program remains open to 
participants of all ages.  
Safe Medicine Disposal for ME 
The Process At a Glance 
• Distribution sites are solicited and trained (Appendix Group 5 includes Distribution Site 
materials) 
• Volunteer staff are trained (Appendix Groups 6 includes Helpline and Volunteer 
materials) 
• Brochures and other educational materials are created, and volunteer staff begin 
presentations in communities (Appendix Group 8 includes Consumer Education Items) 
• Volunteer staff distribute postage-paid, padded return envelopes to pharmacies and 
other health and social service agencies across the state at no cost. (Appendix Group 7 
includes information on Mailback Materials). 
• Pharmacy and agency staff give an envelope which includes an instruction packet 
(Appendix 7A) and a consumer survey (Appendix 7C) to any interested participant. 
o Participants are asked to use a black permanent marker to write over the name of 
the person for whom the prescription was written. They are asked not to write 
over the name of the medicine or the dose. 
o Liquids or creams are to be wrapped in a paper towel and placed in a Ziploc bag. 
o Sealed medicine bottles along with any Ziploc bags of liquid are to be put into the 
padded self-addressed return envelope and sealed. 
• Participants return the completed survey and drugs to the Maine Drug Enforcement 
Agency (MDEA) using the postage-paid return envelope provided. 
• Participants are asked to write down the envelope code written on the corner of the 
medicine envelope and call the program help line to leave a message with the envelope 
code and the date it was mailed. 
• Envelopes are received and held by the U.S. postal service. 
• Drug enforcement agency officials pick up collected envelopes periodically and take to a 
secure central location where they are logged and catalogued.  Questionnaires are 
returned to the Center on Aging for analysis at the time of cataloging. 
• Medicine is destroyed via incineration. 
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Figure 4. Map of Phase I and Phase II distribution locations showing township population density 
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Figure 5.  Map of Phase III distribution locations showing township population density 
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The Mailer  
 
Center on Aging staff tested a variety of padded mailers. There are many to choose 
from depending on project budget constraints, and selecting the size of a chosen mailer 
will have cost implications.  Minimally, mailers need to have a tamper-evident seal and 
should be nondescript--not easily identifiable as containing drugs.  Mailers chosen for 
Safe Medicine Disposal for ME are 7.25 x 12 inches and can hold four different bottles 
of prescriptions and six to eight ounces of drugs, although it has held up to a pound of 
drugs.  The specific mailer chosen was the XPak mailer manufactured by Polyair. 19 
 
Figure 6.  Stack of mailback envelopes 
In Maine, each mailer is 
accompanied by a questionnaire 
along with an instruction booklet on 
how to properly prepare and mail the 
envelope (see Appendix Group 7).  
The questionnaire is designed to 
assess the nature of the returned 
product(s) as well as reasons for 
their return. Information collected 
includes basic demographic data, 
source of contents, patient 
identification of contents and reasons for surplus.  
During Phases I & II, 9,400 envelopes were distributed and 3,926 envelopes were 
returned generating 2,373 pounds of unused and unwanted medicines.  As reported by 
the Community Medical Foundation for Patient Safety, almost 17% of medications 
returned through the Maine Program were found to be controlled drugs (see “What We 
Have Discovered” section of this report). Older medications have not been uncommon; 
some of the prescriptions returned were noted to be twenty or more years old. It is also 
                                             
19 For more information visit www.xpak.com 
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estimated that several of the envelopes returned to date have contained enough unused 
narcotics to net thousands of dollars if sold on the street. 
The Mail System & The USPS 
 
In Maine, an “operational test agreement” was formed between the U.S. Postal Service 
and the Maine Drug Enforcement Agency – the first of its kind.  Operational test 
agreements are traditionally crafted so the postal service can test out novel options.   
 
These agreements are time limited 
contracts, and each state will need to 
pursue an agreement within their own 
state.  Because there had been no 
previous template for this sort of 
agreement, the process in Maine took 
more than a year to finalize. Important 
decisions to be made include the type of 
mailer to be used, how to educate the 
public about the program, and how to 
ensure the safe delivery of envelopes to 
the receiving drug enforcement agency. A copy of the Memo of Understanding between 
the U.S. Postal Service and the Maine Drug Enforcement Agency is provided in 
Appendix 4D. 
 
 
Figure 7. Phase I envelope shipments to  
distribution sites were prepared in-house at the 
Center on Aging 
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Figure 8. CoA staff member prepares Phase I envelope shipment to pharmacies  
 
 
Figure 9. Phase I boxes ready for shipment to program sites 
 
 
 
 
 
 
 
 
 
When The Mailers Come In, Then What? 
 
Using a double verification process, MDEA law enforcement personnel count and 
collect returned mailers from the Post Office on a regularly scheduled basis and take 
them directly to a secure consolidation facility. The audit process involves a repeat 
count of the number of packages received and verification of accounting logs conducted 
by the UMaine Center on Aging.  Throughout the process the MDEA maintains 
continuous, unbroken custody of the returned medicine. 
 
Cataloging of returned drugs was done under law enforcement supervision by volunteer 
project pharmacists and pharmacy students. As participation has increased over time, 
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the program has moved from cataloging 100% of returns to a 25% random sample to a 
20% random sampling procedure. Using a sampling method was found to be both cost 
effective and yielded a data sample that was statistically representative of the full 
inventory data set. For the envelopes that do not receive a full inventory, all non-
controlled drugs are sorted for disposal, and all controlled drugs are fully inventoried.   
 
During the cataloging, drugs were sorted according to whether they were controlled 
drugs or not and further into controlled hazardous or controlled non-hazardous 
categories.20  This sorting method facilitates appropriate disposal and therefore helps 
control disposal costs.  
Figure 10. Volunteer pharmacists and pharmacy 
staff inventory returned medicine 
 
 
 
 
 
 
 
 
 
 
Figure 11. Boxes of inventoried medicine 
 
 
 
Figure 12.  Drugs are occasionally returned mixed 
together and without their original container. 
 
 
Figure 13.  Returned consumer surveys 
collected at a drug inventory event. 
 
 
 
                                             
20 Very few drugs have been found to be both controlled and hazardous. 
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Disposal Mechanics 
 
Various methods of disposal, good and bad, for collected prescription drugs have been 
traditionally used by consumers and facilities including:  flushing down the toilet, 
throwing medication out in the trash, burying in a landfill, burning, or mixing substances 
with kitty litter and used coffee grounds to make results undesirable.  In Maine, drug 
disposal options were to be considered if they satisfied the requirements and standards 
of the Department of Environmental Protection and the Maine Drug Enforcement 
Agency. Maine DEP has classified drug returns as hazardous waste, while other states 
may classify drugs differently. All non-controlled drugs collected by the mailback were 
incinerated as hazardous waste. All controlled drugs were disposed of through 
incineration with a witness from the Maine Drug Enforcement Agency to certify that the 
drugs were in fact destroyed.  
 
Collection, Inventory and Disposal Requirements 
 
In compliance with the Maine Drug Enforcement Agency and the Department of 
Environmental Protection, drug collection, inventory and disposal included the 
following elements:  
 
1) Double verification of returns  
 
2) One secure collection and consolidation facility 
 
3) Repeat count of the number of packages that have been received 
 
4) Proper disposal of all drugs collected 
 
5) Continuous, unbroken custody by law enforcement from receipt to disposal 
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Volunteer Workforce: Elder Involvement is a Critical Component 
 
It cannot be stressed enough how important volunteers, in particular older adult 
volunteers, are to the program.  The first two external groups to be developed, the 
Community Advisory Board and the Distribution Site Educators, are outlined below. 
Members were recruited by print, broadcast, and word-of-mouth. 
 
In Phase I, the 15-member Community Advisory 
Board was comprised of volunteers age 65 and 
older recruited from the Retired Senior Volunteer 
Program (RSVP), Maine Area Agencies on 
Aging, and other older adult organizations and 
associations from urban, rural, and suburban 
areas in each county represented in the pilot 
project.  Board members reflected the 
population’s diversity by gender, socioeconomic 
status, and education. In the early stages, 
Community Advisory Board members attended monthly meetings and acted as a 
sounding board for the project, in part to review brochures, instruction booklets, and 
marketing strategies for applicability to an elder community.  The board has also 
provided valuable insight into the rural Maine communities represented by individual 
members. 
 
Volunteer Distribution Site Educators included community members from around the 
state and Community Advisory Board members.  In Phase I, their purpose was to 
deliver mailers and materials and to educate distribution site pharmacists and staff 
about the program process. This role was discontinued for a variety of reasons, one 
being that pharmacies were often too busy to meet with Educators and orientation 
materials as designed were fairly self-explanatory. Beginning in Phase II, Educators 
organized and attended meetings at local Chambers of Commerce, Kiwanis clubs, 
senior centers, and nursing homes to educate members of their own communities about 
Figure 14. Community Educator 
volunteer orients community 
pharmacist to the mailback program 
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the mail-back program. Presentations included a PowerPoint slideshow, a presentation 
quiz, and handouts (Appendix Group 8).  
 
Evaluation data for community education sessions were gathered via a post-session 
survey tool. One hundred and fifty-one surveys (151) from education session 
participants were gathered and analyzed. Participants in community outreach and 
education presentations range in age from 20 to over 80 years old. The majority of 
participants were within the 60-80+ age range. Eighty-seven percent of participants are 
female and 13% are male. Ninety-four percent (94%) of participants had never 
participated in a community drug disposal event prior to attending the education 
session. This indicates that the presentation is often touching upon new topics and 
disposal issues to which participants had not yet been exposed.  Ninety-seven percent 
(97%) rated the overall drug disposal presentation as “good” or “excellent.” The average 
exam score on post-presentation evaluations was 95/100 indicating that the training has 
a high level of impact on knowledge. A sampling of comments from education session 
participants:  
 
• Very helpful/informative 
• This information is very important! 
• Hank (CAB volunteer) has a wonderful way of presenting and relating to people. 
His talk was very well received by folks at the Knox county TRIAD meeting 
• Very necessary information! Well done! 
• Lynn (CAB volunteer) was great with the women attending! 
• Well done! / Good job! 
• Important information-much needed in our community! 
• It is my understanding when people take meds, then urinate, the meds end up in 
the sanitation systems and cause gender confusion. 
• Great! Entertaining and informative 
 
An additional avenue for volunteering with the Maine program was the use of volunteer 
pharmacists from distribution sites who were recruited to catalogue returned drugs. 
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Pharmacy tech staff and students volunteered their time under supervision of the 
pharmacists to assist in data collection.  This assistance was provided by Miller Drug, a 
local community pharmacy, volunteer licensed pharmacists, along with faculty and staff 
from Husson University School of Pharmacy, and the University of New England 
College of Pharmacy.  
Communication Systems 
 
The mailback program utilized several project-specific communication vehicles, two-way 
communication “channels,” to stay in touch with a primary network of advisors and to 
interact with the public: meetings, a consumer website, and a helpline.  In addition, the 
Center’s newsletter Silverwire often contained project updates.  Two-way 
communication allowed the project to be responsive to unanticipated problems. 
 
Regular meetings of both the Technical Advisory Board and the Community Advisory 
Board offered an opportunity for the project staff to share successes and problem-solve, 
and to receive and send feedback to/from the public and other concerned stakeholders.   
 
The project website (www.safemeddisposal.com) provided a “one-stop-shopping” 
solution for people who wanted to know about the project or check policy changes. The 
website was heavily used by both local and out-of-state persons interested in the 
project.  In addition, website visitors were able to send an email inquiry to project staff.  
During the last most recent reporting period, for example, project staff received 
approximately one email a day during the work week. E-mail was used most by 
caregivers and professionals. Caregiver requests were usually for an envelope to be 
mailed to them because a nearby site location was not available via the program. 
Professional inquiries tended to come from pharmacies and other sites interested in 
participating in the program. Additional requests that came in by e-mail were from other 
states looking for information on the program for replication purposes. A sampling of 
states requesting information about the program model include: Oregon, Washington, 
D.C.; New York; California; Florida; New Hampshire; and Washington. As an example 
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of the national impact of the pilot, please see the U.S. Postal Service press release in 
appendix group 4.  
 
The helpline, which was staffed by student interns, proved to be a very critical 
component of the program communication system.  This phone number was liberally 
circulated to pharmacies and community sites, and was found on virtually all program 
informational material.  During a recent three-month reporting period, the project 
received 727 calls, an average of more than 10 a day during the workweek.  Two 
thousand seven hundred and seventy-seven (2,777) calls were received over the 2.5 
year reporting period.  Many of these have been from individuals calling the program to 
alert staff that they were mailing an envelope. Additional sources of inquiries included 
pharmacies, healthcare, and community sites that are interested in becoming 
established distribution sites.  Thus the helpline functions in recruitment as well as 
information exchange. 
 
 
 
 
 
 
 
Feedback Loops: Tracking and Evaluation 
 
Feedback loops existed as a function of the evaluation forms distributed at each 
community education event. These events were usually staffed by volunteer community 
educators trained for the project.  In addition, each mailer contained a short survey, 
which was designed to learn about the demographic profile of the participant, the 
reasons for participating, the sources of the drugs, and the reason they had 
accumulated. 
Communication “Channels” 
1. Advisory board meetings 
2. Project website 
3. Project helpline 
4. Agency newsletter 
5. Media releases 
6. Public presentations 
7. Evaluation forms at community education sessions 
8. Survey instruments inside mailers 
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But beyond these basic tracking mechanisms, a thoughtful program evaluation should 
be a critical component of any publicly funded effort.  Without well-designed evaluation 
methods, programs do not have systematic ways to measure success, to improve 
systems, or (minimally) to programmatically account for their expenditure of public 
monies.   
 
Program evaluations should track and account for whether the program meets is 
benchmarks along the way as outlined in the workplan (formative evaluation).  These 
feedback mechanisms should be built into the project’s internal information systems.  In 
addition, program evaluations should assess whether the project met its overall goals, 
as indicated by measurable outcomes (summative evaluation).  Programs often find it 
challenging to identify outcome measures that clearly reflect the efforts of the project in 
achieving its goals.   
 
If they are to be used for quality improvement, outcome measures should ideally be 
selected to reflect processes over which the project has some control and which move it 
toward its selected goals.  In other words, depending on the outcomes, one should be 
able to actively “tweak” the systems, if necessary, in order to get an improved result.  
The link between program effort and its outcome should be clear (visible) and 
measurable (ideally by an objective observer) in either qualitative or quantitative terms.  
It is only when both the process and outcomes are documented that the program has 
the potential to become “evidence-based,” evidence being the best source of informed 
policy.  
Public Relations and Marketing 
 
A unique education campaign was implemented for Maine in two phases. In Phase I, 
education provided by the program was done via the program website and program 
brochures and tipsheets. The purpose of these materials was to enlighten the public on 
the hazards to life and health posed by unused drugs. The explicit message and goal 
was to reduce/eliminate unused medications in circulation and improper disposal 
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because of the significant potential for human and environmental harm as well as to 
advance public knowledge about protecting, sustaining and restoring the environment. 
The Phase II campaign built upon the messages established in Phase I and 
incorporated a new message encouraging the public to visit distribution sites statewide 
to acquire and use mailers. Phase II education efforts were rolled out locally via multiple 
media channels and local in-person presentations by volunteers in a more extensive 
and purposeful fashion than in Phase I to measure the impact that such education 
would have on the use of the program.  
 
Because of the higher rate of pharmaceutical usage among older adults and the higher 
risk of accidental misuse and/or overdose within this population, special emphasis was 
placed on crafting cohort-specific messages during both phases and utilizing 
communication channels targeting specific user groups.  
Effective Use of the Media 
 
Communication with the public via print, digital, and broadcast media constitutes an 
essential part of program planning (see Appendix Group 9).  The University of Maine’s 
Public Affairs department was routinely used as a vehicle to develop and circulate press 
releases.  Staff generated program drafts of press releases and welcomed input from 
those who specialize in this type of communication.  Relationships between programs 
and such specialists, including public information officers, journalists, news anchors, 
and other writers can be very helpful in designing interesting and appropriate material 
that targets particular readerships/audiences.  They used material the program 
generates and augmented it for their particular purpose, sometimes with an interview of 
program staff or program volunteers. 
 
Program staff encouraged volunteers and partner organizations to “get the word out” by 
providing basic informational materials so that there was a uniform source for basic 
facts and concepts while leaving room for each outlet to augment the material as 
appropriate.  For example, a media template was provided to local papers and 
community contacts that could be used as a backdrop for a story about a local person, 
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group, or educational event.  An example of the template is included in Appendix Group 
9. 
 
Material generated for local community education, such as PowerPoint presentations, 
was made accessible for interested and involved citizens to use.  This accessibility is 
important in increasing the speed at which a new idea (the drug mailback concept) can 
reach a large number of people.  In this way, media and publicity efforts dovetailed with 
the heavy use of volunteers for outreach, training, and communication. 
The Value of Research 
 
Whether or not you plan to do any formal research as a part of your mailback program, 
research findings will nevertheless flow from your efforts.  The experience gained by 
conceiving, planning, and implementing this program will include conclusions based on 
information.  It will probably also include evaluation findings about how you reached 
your objectives, how well certain efforts worked, and ways your program is similar or 
different than others like ours.  We strongly recommend that, at a minimum, you take 
advantage of your experience by carefully documenting your plans, progress, and 
experience.  Your documented findings will be of use in (1) educating others about your 
program, (2) building political support for future programs, (3) writing proposals to 
funding agencies to obtain funding, and (3) designing public policies in your region and 
nationally. Simply collecting weight or estimated dollar value of the drug returns 
collected provides very little precise data on which to formulate policy or useful insights 
on drug accumulation.  
 
Some levels of research are limited by resources, but should be attempted if possible.  
In particular, cataloging the drugs returned requires secure settings and professional 
input from pharmacists and healthcare volunteers, as well as some research skills to 
analyze the results.  Ideally, funding is allocated in your budget ahead of time for some 
research.  Sometimes, as is the case for the Maine program, volunteers can boost your 
efforts.  For example, local schools of pharmacy may be interested in using this as an 
educational experience for students.  The program also partnered with the Community 
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Medical Foundation for Patient Safety in Texas, which is working to establish a national 
database of drug returns to assist in research design and data analysis. 
 
Take-back programs are in their infancy, but growing fast.  Because of their potential 
impact on environmental policy, healthcare policy, and public safety, it is very important 
that good data are developed describing their scope and impact. Knowledge about the 
amount of excess drugs collected in Maine has been informative in refining Maine 
Medicaid policy, for example, leading to limits for some drugs on how much can be 
prescribed (see Appendix 4F regarding the new 15-Day Rule).  And the Maine state 
legislature, along with other states, is considering new product stewardship laws that 
would require pharmaceutical companies to cover the cost of drug disposal. 
What We Have Discovered with Our Program Research 
 
The short survey included with each mailback envelope yielded vast amounts of data on 
the demographic characteristics of participants, the reasons drugs had accumulated in 
their households, and reasons for participating in the program. Each envelope has a 
code number pre-printed on the front which allows for linking survey data directly to 
drug inventory data. Several databases are currently maintained by the program 
including: envelope tracking and distribution databases, a survey database, a database 
with community education session evaluations, drug inventory data, and helpline 
communication logs.  These data are valuable indicators for future programs and helpful 
for designing program materials and community education. 
 
As the program continued into Phase II, increasing demand by non-pharmacy 
organizations lead to the expansion of distribution channels to a wider range of 
distribution sites, including home health agencies, doctor’s offices, social service 
programs, and Area Agencies on Aging. After examining returns patterns, a trend was 
noted that revealed that returns are directly related to the population size within the 
areas where sites are located. However, the rate of return for each site was not 
calculated.  As such, site locations and distribution patterns for the program were 
modified to ensure that envelope stock is used in an efficient and appropriate manner.  
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Maine’s program was targeted for elders initially, although program staff quickly 
anticipated that it made sense to expand to adults of all ages given the drug abuse and 
death trends within the state.  However, it was discovered that starting with older, retired 
citizens was a very effective strategy to launch this new concept.  First of all, they are 
likely to have more prescriptions and more likely to be willing and available to assist in 
the program as volunteers.  The average age of program users in Phase I was found to 
be 70 years of age; once the program opened up to adults of all ages, the average age 
of program participants (those who return drugs using the envelopes) was found to be 
59 years, with 65% of participants being female. Households participating in the 
mailback program were more likely to have adults rather than children living in the 
household. However, nearly one quarter of the participating households had a teenager 
Safe Medicine Disposal for ME Phases I & II 
Snapshot 
 
• $150,000 in funding provided by the U.S. EPA to pilot in Phases I & II 
9,400 envelopes distributed 
• 3,926 envelopes collected (42% return rate) 
• Over 380,000 pills cataloged via the drug inventory process 
• 2,074 surveys collected and analyzed 
• 2,777 telephone calls answered via the program helpline 
• 2,123 pounds of non‐controlled drugs destroyed 
• 250 pounds of controlled drugs destroyed 
• Average weight of a returned envelope: 7 ounces 
• Estimate Average wholesale price (AWP) of medicine collected: $572,772.35 (US 
Dollars)* 
• Value of donated envelopes by Polyair, donated time by Principal Investigator, 
pharmacist, student, and volunteer time donated to the program:  $26,607.13** 
 
Percentage of individuals using trash or toilet to dispose of drugs prior to the program = 
83% x 2,373 lbs of drugs = 1,970 lbs of drugs prevented from entering the water supply 
and landfills 
 
*Estimate provided by Community Medical Foundation for Patient Safety based on sampling. MAC, or 
Maximum Allowable Cost, was not calculated 
 
** See “The Bottom Line” section of this report.
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in the household or a child under the age of 10 years old. This information was tracked 
to measure the potential for preventing accidental poisonings or drug diversion. 
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Participants indicated a number of reasons the drugs had accumulated in their 
household.  The most frequent reason given was that the medicines were now expired 
or outdated.21 The second most common reason was that the doctor had told the patient 
to stop taking the medicine.  Other reasons were that the doctor had given them a new 
prescription, that they had had a negative reaction or allergy to the medicine, or that the 
patient felt better or no longer needed the medicine.  A substantial number of 
participants wanted to prevent anyone else from using the medicine. The open-
response option for this question also yielded a considerable portion of respondents 
who were returning medicine for a deceased loved one. Based on these data, we began 
tracking the portion of respondents returning medicine for a deceased family member or 
friend. Most drugs returned via the program were obtained at a local pharmacy (84%) or 
by mail (14%).  
                                             
21 Older medications were not uncommon.  Some were prescriptions noted to be as many as 20 or more years old. 
Figure 15. Household Makeup of Mailback Program Users 
Safe Medicine Disposal for ME: A Handbook and Summary Report  ? April 2010 47 
 
47.4
31.1
27.3
25.4
24.2
18 12.2
11.9
7.2
0.7
0
10
20
30
40
50
%
Why do you want to get rid of these medicines?
N = 2,041
Expired
Doc told me to stop taking it
Doc gave me new medicine
Did not want anyone else to
use it
Other
Felt better
Didn't like the side effects
Had a reaction or allergy
Didn't want to take it
I don't know
Reason  
 
Our survey findings show that keeping household medications organized and up-to-date 
can be an important and constant chore, not only for patients, but also for their 
caretakers. In fact, while 41% were returning medicine for themselves, thirty-five 
percent (35%) were returning medicine for a relative, and nearly 20% were returning 
medicine for a deceased friend or loved one22.  The decision about what to dispose of 
can be complex as indicated by the fact that 16% of our respondents did not know what 
kind of medicine they were returning. 
 
                                             
22 Many survey questions allowed the respondent to select more than one response option thus not all percentages 
within the charts provided will add up to 100% 
Figure 16. Reasons for Unused/Unwanted Medicine 
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Prior to this program, participants said that they usually flushed medications down the 
toilet (46%) or placed them in the household trash (37%).  A smaller number said they 
had attended community drug collection events (5%). 
 
Most participants (77%) indicated that concern for the environment was a significant 
factor in their decision to use the mailback program and 16% cited safety for themselves 
and their families.   
Figure 17. Source of Medicine Returned 
Figure 18. Type of Medicine Return: Self Report 
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A very important source of data about our program came from the cataloguing of the 
drugs themselves.  We received mostly pills, but also gels, creams, inhalers, and other 
items.  Nearly all (86%) of the returns were prescription drugs, and 12% over-the-
counter.  The vast majority of returns represented prescription drugs consumed by 
humans as compared to the negligible amount of veterinarian medicines returned using 
the program.  
 
Figure 19. Disposal Methods Used Prior to Mailback Program 
Figure 20. Controlled Drug Status of Returned Medicine 
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About 17% of the drugs were schedules II, III, and IV –“controlled drugs.”  These 
include narcotic pain relievers, tranquilizers and sedatives, as well as stimulants. These 
are the drugs that are sometimes diverted for “street” use or sale.  Controlled 
substances were equally likely to be returned by males (14%) and females (15%) (no 
statistically significant difference). The rate of controlled substances returned increased 
slightly with age, but the differences were not significant. 
 
 
 
 
Figure 21. Over-the-County Returns vs. Prescription Medicines 
Figure 22. Human vs. Veterinarian Medicines Returned 
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Most returns were in pill form. Fourteen percent of returns represented liquids, gels, 
ointments and patches. A negligible amount of medical supplies and devices were 
returned including unused morphine pumps.  
 
 
Full, unused bottles were sometimes returned, including prescriptions from mail-order 
pharmacies or VA pharmacy services, as well as anti-retroviral drugs for HIV/AIDS 
treatment.  It was not uncommon to find a mix of local and mail order pharmacies 
represented sometimes where a patient was receiving the same drug from both 
sources. 
 
Drug data were classified into therapeutic categories by the Community Medical 
Foundation for Patient Safety using the Drug Abuse Warning Network system (DAWN). 
The following chart produced by the Community Medical Foundation for Patient Safety 
demonstrates that the CNS agents, cardiovascular agents, and psychotherapeutic 
agents were the top three categories of drugs returned through the program.  
 
Figure 23. Form of Returned Medicines  
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Figure 24. Therapeutic Category Breakouts of Returned Drugs by Number of 
Prescriptions/Medications Collected 
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FREQUENCY COUNT BY THERAPEUTIC CATEGORY, THERAPEUTIC SUBCLASS 1, 
THERAPEUTIC SUBCLASS 2 
(Total=11382 Items) 
 
THERAPEUTIC CATEGORY--                    
Therapeutic Subclass 1                            
Count of 
Therapeutic 
Category % 
No therapeutic category available 328 2.88 
ALTERNATIVE MEDICINES 59 0.52 
Drug names not available 6  
Herbal products 26  
Nutraceutical products 19  
Probiotics 8  
ANTI-INFECTIVES 776 6.82 
Drug names not available 4  
Amebicides 42  
Aminoglycosides 10  
Anthelmintics 1  
Antifungals 62  
Figure 25. Therapeutic Subclass Breakouts of Returned Drugs by Number of 
Prescriptions/Medications Collected 
Difference Noted on Therapeutic Classes of Drugs Returned 
 
A subset of data was examined to determine gender and age‐related 
differences among users and the drugs they returned: 
 
• Males returned more anti‐infectives, cardiovascular agents and metabolic 
agents. 
 
• Females returned more gastrointestinal agents, hormones, psychotherapeutic 
agents and respiratory agents [Chi sq. = 39.52, df = 14, p < .000]. 
 
• Participants 50 years of age and younger were less likely than their older 
counterparts to return most classes of drugs, with the exception of 
psychotherapeutic agents. 
 
• Top drug classes by age are as follows: Participants 75 or older: cardiovascular 
agents (19%); 65 to 74: hormones (7%); 50‐64: metabolic agents (17%). 
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Antifungals, Azole antifungals 12  
Antimalarial agents 8  
Antituberculosis agents 1  
Antiviral agents 33  
Cephalosporins 97  
Cephalosporins, First generation 
cephalosporins 16  
Dermatological agents 1  
Leprostatics 1  
Lincomycin derivatives 27  
Macrolide derivatives 72  
Miscellaneous antibiotics 5  
Penicillins 151  
Quinolones 97  
Sulfonamides 57  
Tetracyclines 54  
Urinary anti-infectives 25  
ANTINEOPLASTICS 42 0.37 
Antimetabolites 3  
Hormones/antineoplastics 37  
Tyrosine kinase inhibitors 2  
BIOLOGICALS 1 0.01 
In vivo diagnostic biologicals 1  
CARDIOVASCULAR AGENTS 1687 14.82 
Drug names not available 1  
Antiadrenergic agents, centrally 
acting 32  
Beta-adrenergic blocking agents 287  
Calcium channel blocking agents 194  
Calcium channel blocking agents,  21  
Cardiovascular agents NTA 671  
Cardiovascular agents NTA, 
Angiotensin converting enzyme 
inhibitors 121  
Cardiovascular agents NTA, 
Angiotensin II inhibitors 8  
Cardiovascular agents NTA, Inotropic 
agents 2  
Diuretics 350  
CNS AGENTS 2613 22.96 
Drug names not available   
Analgesics 1991  
Analgesics, Miscellaneous 4  
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analgesics/combinations 
Analgesics, Nonsteroidal anti-
inflammatory agents 1  
Anorexiants 2  
Anticonvulsants 231  
Anticonvulsants, Fatty acid derivative 
anticonvulsants 26  
Antiemetic/antivertigo agents 123  
Antiparkinson agents 50  
Miscellaneous CNS agents 76  
Muscle relaxants 101  
Muscle relaxants, Skeletal muscle 
relaxants 6  
COAGULATION MODIFIERS 168 1.48 
Anticoagulants 122  
Antiplatelet agents 39  
Miscellaneous coagulation modifiers 7  
DRUG UNKNOWN 172 1.51 
GASTROINTESTINAL AGENTS 733 6.44 
Drug names not available 6  
5-aminosalicylates 15  
Antacids 18  
Antidiarrheals 65  
Digestive enzymes 14  
Functional bowel disorder agents 50  
Functional bowel disorder agents, 
Serotoninergic neuroenteric 
modulators 2  
Gallstone solubilizing agents 5  
GI stimulants 41  
H2 antagonists 78  
Laxatives 172  
Laxatives  4  
Miscellaneous GI agents 28  
Proton pump inhibitors 235  
HORMONES 441 3.87 
Drug names not available 1  
Adrenal cortical steroids 170  
Bisphosphonates 29  
Miscellaneous hormones 22  
Sex hormones 110  
Sex hormones, Contraceptives 2  
Thyroid drugs 82  
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Thyroid drugs  25  
IMMUNOLOGIC AGENTS 12 0.11 
Bacterial vaccines 1  
Immunosuppressive agents 9  
Viral vaccines 2  
METABOLIC AGENTS 765 6.72 
Drug names not available 6  
Antidiabetic agents 284  
Antigout agents 63  
Antihyperlipidemic agents 382  
Antihyperlipidemic agents, HMG-CoA 
reductase inhibitors 21  
Glucose elevating Agents 9  
MISCELLANEOUS AGENTS 169 1.48 
Drug names not available 13  
Antidotes 5  
Antirheumatics 3  
Chelating agents 3  
Genitourinary tract agents 100  
Miscellaneous uncategorized agents 29  
Smoking cessation agents 15  
Viscosupplementation agents 1  
NON-ALCOHOL ILLICITS 5 0.04 
Stimulants 5  
NUTRITIONAL PRODUCTS 377 3.31 
Misc 19  
Iron products 9  
Minerals and electrolytes 145  
Oral nutritional supplements 1  
Vitamin and mineral combinations 86  
Vitamins 117  
OTHER 12 0.11 
PSYCHOTHERAPEUTIC AGENTS 1672 14.69 
Antidepressants 610  
Antipsychotics 300  
Antipsychotics, Miscellaneous 
antipsychotic agents 27  
Anxiolytics, sedatives, and hypnotics 565  
CNS stimulants 170  
RESPIRATORY AGENTS 789 6.93 
Drug names not available 1  
Antihistamines 180  
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Bronchodilators 275  
Decongestants 36  
Expectorants 13  
Respiratory agents NTA 123  
Upper respiratory 1  
Upper respiratory combinations 160  
TOPICAL AGENTS 561 4.93 
Drug names not available 7  
Anorectal preparations 6  
Antiseptic and germicides 8  
Dermatological agents 209  
Dermatological agents, Topical     
antibiotics 3  
Mouth and throat products 10  
Nasal preparations 80  
Ophthalmic preparations 198  
Ophthalmic preparations, Ophthalmic 
glaucoma agents 12  
Otic preparations 11  
Vaginal preparations 17  
Grand Total 11382 100.00 
 
 
Through research both the environmental risk and the environmental hazards of the 
drugs returned through the program were assessed. All items for which data were 
available were found to pose at least some environmental risk. Environmental risk refers 
to risk of acute toxicity to the aquatic environment. Environmental risk is based on the 
ratio of predicted environmental concentration of the substance (PEC) and the highest 
concentration of the substance that does not have a harmful effect in the environment 
(PNEC)23.  Environmental Risk is specified as follow: 
 
Risk  Condition          Value 
Insignificant  if PEC/PNEC  <0.1  
Low   if PEC/PNEC  0.1–1 
Moderate  if PEC/PNEC  1–10 
                                             
23 More detailed information is available at www.fass.se and 
www.janusinfo.org/imcms/servlet/GetDoc?meta_id=7236 
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High   if PEC/PNEC  >10 
POTENTIAL ENVIRONMENTAL RISK 
(DF=33, Var Name=RISK) 
(Total=11382 Items) 
 
 
 
 
The potential environmental hazard assessment of the active pharmaceutical substance 
is based on the three characteristics of persistence (P), bioaccumulation (B), and 
toxicity (T). Each characteristic is assigned a numeric value (0–3). The total of the 
values comprises the PBT Index of the substance with 0 being the lowest PBT rating 
and 9 being the highest score representing the highest degree of environmental hazard. 
Environmental hazard assessment is based on the JANUS Classification System, 
accessed at http://www.janusinfo.se/imcms/servlet/GetDoc?meta_id=6913.   
 
JANUS Classification System (Janusinfo) is a public-domain website that provides drug 
information to support healthcare professionals and environmental scientists to 
understand better the wide range of pharmaceutical products and their potential impact 
on the environment. The Drug Therapeutic Committees and the Department of Drug 
Management and Informatics in Stockholm County Council, Sweden maintain this 
website and periodically update the information.   
 
 
Figure 26. Potential Environmental Risk of Returned Medicine  
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POTENTIAL ENVIRONMENTAL HAZARD 
(DF=34, Var Name=PBT; DF=35, P; DF=36,B; DF=37,T) 
(Total=11382 Items) 
 
 
 
 
Classification is made of both the medicines’ inherent ability to affect the environment 
(environmental hazard) and the environmental risk posed by the pharmaceutical 
substances when used to their current extent. The Environmental Department of 
Stockholm’s County Council initiated the environmental hazard assessment based on 
data submitted by pharmaceutical manufacturers in 2003. The classification system 
includes environmental risk assessment, which was conducted by the Swedish 
Association of the Pharmaceutical Industry in 2005. 
 
While the Swedish and European pharmaceutical market overlaps with that of the U.S., 
some medicines (generic categories) available in the U.S. may not be listed in the 
current JANUSINFO.  Project Investigators along with the Community Medical 
Foundation for Patient Safety researched and evaluated many classification systems for 
the National Unused and Expired Medicines Registry and has determined that 
JANUSINFO is appropriate and efficient in characterizing the relative potential 
Figure 27. Potential Environmental Hazard Posed by Returned Medicine  
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environmental risk and hazard of UEMs.  The scientific basis of JANUSINFO follows 
industry guidelines established by the U.S. Department of Health and Human Services, 
U.S. Food and Drug Administration, and the Organization for Economic and Co-
operation for Development (OECD).  OECD is a 30-country membership body 
established in 1961 to monitor, create standards, and present recommendations to help 
governments foster prosperity and fight poverty through economic growth and financial 
stability, as well as to ensure and address environmental implications of economic and 
social development. 
 
In general, the standards and recommendations for environmental risk and hazard 
assessments are more stringent in Europe than those in the U.S.  For more technical 
information and description of these standards, refer to the publication Environmental 
Classification of Pharmaceuticals.24   
 
Environmental risk and hazard data point to the need for disposal program options and 
communication campaigns that educate the public about the potential environmental 
impact of drugs that have been disposed of improperly. Findings from the mailback 
program indicate that, for drugs where environmental impact data were available, there 
was at least some risk or hazard present among the returns. Approximately 43% of the 
drugs collected were found to be a hazard to the environment and 50% of the returns 
presented environmental risk.  
 
Conclusions 
Maine’s citizen mailback program has demonstrated that this approach is not only 
feasible, but effective.  The program utilized a phased implementation, beginning by 
targeting elders and focusing on pharmacies as distribution sites for the mailback 
envelopes.  We then phased in a broader target population, adults of all ages, as well 
as a broader range of distribution sites (other providers of health services).   
 
                                             
24 Contact the Community Medical Foundation for Patient Safety for more information: 
www.communityofcompetence.com 
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The mailback envelope take-back method returned a large quantity of drugs that would 
have otherwise been disposed of directly into the water system through flushing or into 
landfills through the trash.  A short survey inserted in the envelope allowed us to track 
the reasons for participation, the sources of the drugs, and the demographic profile of 
the participants.  This is information that is useful not only for project planning and 
education, but also policy development. 
 
The mailback program provides a rich opportunity to educate a broad public citizenry 
about prescription drugs and the environment via community outreach and information 
distributed with the mailer.  It involves citizens in an easy, “DIY” (do it yourself) problem-
solving program that prevents environmental harm, prevents drug diversion, and 
prevents poisoning. Community education by older adults was found to be both effective 
and engaging while encouraging new users of the program to spread the word in their 
local communities. It is for this reason the consumer involvement should be a key 
component in any drug return program model.  
 
The major challenge for this and other disposal programs continues to be funding to 
sustain such efforts.  All disposal programming, whether mailback or event-based 
takeback programs, require a considerable amount of time and effort to plan, execute, 
and educate the public. Our first two phases have shown us that the interest and the 
community need exist and in fact, clearly outweigh the resources available to address 
the issue of drug disposal. However, it is imperative to continue as many programming 
and outreach efforts as possible to provide drug disposal options directly to the 
consumer at the same time that information is disseminated so as to avoid the 
confusion and misinformation the surrounds the issue of drug disposal.  
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Safe Medicine Disposal for ME 
Contact Information 
 
Daily operations: 
Jennifer Crittenden, M.S.W. 
Project Director 
Research Associate 
UMaine Center on Aging 
jennifer.crittenden@umit.maine.edu 
207-262-7923 
 
Project administration: 
Lenard Kaye, D.S.W./Ph.D. 
Principal Investigator 
Director and Professor 
UMaine Center on Aging 
len.kaye@umit.maine.edu 
207-262-7922 
 
Technical/Scientific issues: 
Stevan Gressitt, M.D. 
Co-Principal Investigator 
Medical Director, Adult Mental Health Services 
Maine Department of Health and Human Services 
stevan.gressitt@maine.gov 
207-287-4273 
 
General Project Information: 
Phone:  1-866-ME-RX-RID (1-866-637-9743) 
Email: info@safemeddisposal.com 
Website: www.safemeddisposal.com 
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APPENDIX 2 
Project Collaborations/Partnerships 
and Leveraged Resources 
 
Maine-Based Organizations 
• Center on Aging, University of Maine 
• Maine Association of Psychiatric Physicians 
• Maine Benzodiazepine Study Group (MBSG) & Drug Disposal Group 
• Maine Council for Child & Adolescent Psychiatry 
• Maine Department of Health and Human Services 
• Maine Department of Environmental Protection 
• Maine Drug Enforcement Agency 
• Maine Office of Adult Mental Health Services 
• Maine Office of Substance Abuse 
• Maine Center for Disease Control and Prevention 
• Maine Office of the Attorney General 
• Maine Office of Elder Services 
• Maine Pharmacy Association 
• Independent pharmacies throughout Maine 
• Maine Retired Senior Volunteer (RSVP) Programs 
• Margaret Chase Smith Center Policy Center, University of Maine 
• Northern New England Poison Center 
• Husson University School of Pharmacy 
• University of New England 
• Maine Medical Association 
• Safe Medicine for Maine 
 
Federal & National Organizations 
• American Pharmacists Association  
• Community Medical Foundation for Patient Safety 
• National Council on Patient Information and Education 
• Office of the U.S. Attorney General 
• Rite Aid Corporation 
• CVS Pharmacies 
• U.S. Drug Enforcement Administration 
• U.S. Environmental Protection Agency Aging Initiative 
• U.S. Postal Service 
• Villanova University Center for the Environment 
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APPENDIX 3 
Project Timeline: Phases I & II of Pilot 
 
• Create consolidation, transportation, and incineration protocols 
• Commence meetings of technical advisory task force 
• Secure network of 75 distribution points (pharmacies) to which mailers are 
distributed in both phases 
• Engage community advisory board members 
• Commence meetings of community advisory board 
• Design and create mailers and accompanying survey, training materials 
for Distribution Site Educators and instructions for pharmacies and public 
• Create web site, establish 800 number call center and create related 
training materials and protocols 
• Engage and train Distribution Site Educators 
• Develop education campaign content and communication dissemination 
plan 
• Launch Phase I education campaign 
• Distribute informational materials for pharmacists, staff, and individuals 
acquiring mailers for Phase I; provide training 
• Collect, inventory and destroy returned products in compliance with 
applicable state and federal laws and sound environmental practices in 
four-county region for Phase I 
• Contract with incineration facilities and transportation contractors 
• Evaluate Phase I and refine for Phase II 
• Launch Phase II education campaign 
• Distribute informational materials for pharmacists, staff, and individuals 
acquiring mailers for Phase II; provide training 
• Collect, inventory and destroy returned products in compliance with 
applicable state and federal laws and sound environmental practices 
statewide for Phase II 
• Generate, analyze and report on survey and inventory data in a manner 
that allows physicians, pharmacists, insurance companies, patients and 
others to modify behaviors to minimize unused medications 
• Conduct final evaluation of project 
• Publish best practices guidebook 
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APPENDIX GROUP 4 
Contextual and Technical Documents 
 
• APPENDIX GROUP 4: Contextual, legal and technical documents and 
agreements that link the project with the following: 
 
o APPENDIX 4A: 2003 Drug Disposal Group meeting minutes‐Legislation 
development for disposal program 
 
o APPENDIX 4B: Final report of the Maine Drug Return Implementation Group 
established through LD 1826 
 
o APPENDIX 4C: U.S. Drug Enforcement Administration Program Review Letter
 
o APPENDIX 4D: U.S. Postal Service and Maine Drug Enforcement Agency Test 
Agreement document 
 
o APPENDIX 4E: Northern New England Poison Center Medication Disposal 
Summary 
 
o APPENDIX 4F: Maine Medicaid program: summary of 15‐day prescription 
policy 
 
o APPENDIX 4G & 4H: 2007 and 2008 Proper Drug Disposal Day Proclamation 
issued by Maine Governor John Baldacci 
 
o APPENDIX 4I: Athens Declaration and Istanbul Statement 
 
o APPENDIX 4J: Ruhoy and Gressitt paper abstract on reasons for drug disposal 
 
o APPENDIX 4K: Postal Service press release on VA mailback program in 
Baltimore, Washington, DC, and West Virginia 
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Drug Disposal Group 
 
Interested Parties Meeting 
 
December 16, 2003 
 
 
Attached is the attendance list. 
 
Introductory Remarks 
 
Senator Lynn Bromley opened the meeting at 10am.  She noted that her goal was to pass 
a bill on this issue, hoping to come out of today’s meeting with an outline. Her deadline 
for drafting legislation is January 6 at the Revisor’s Office.  Let’s not make perfect the 
enemy of the good, she suggested.   
 
The group represented a wide variety of constituencies and viewpoints.  As individuals 
introduced themselves and stated their reasons for attending the meeting, Senator 
Bromley noted the priority categories into which they fell.  Seven said they were here for 
diversion issues, nine regarding waste issues, five for education, three for mistaken 
prescriptions, and two for security issues. 
 
Karen Simone from the Poison Center noted that the center would support anything 
environmentally sound, as they used to recommend flushing because of the speed with 
which you could get rid of it.  She noted that garbage cans are not safe for kids and are 
often raided by drug abusers.  We need to make sure we’re not making these drugs more 
accessible. 
 
Many members of the state’s environmental community, including the state’s fish 
pathologist, biologist, as well as the state geologist, attended and raised concerns 
regarding the impact of drug disposal on groundwater.  They noted that a lot of work is 
being done on the downstream effects of flushing prescription drugs.  Ann Pistell of the 
DEP said that they deal a lot with product stewardship issues, which has a role in this 
discussion.  Scott Austin of the DEP noted that he deals with hospitals on this issue and 
that there are no hospital incinerators left in Maine.   
 
We were joined by Laurie Tenace of Florida who is working on this issue regarding 
pharmaceuticals and personal care products.  She is scheduling a teleconference on this 
issue in January. 
 
The Rite-Aid representative noted that we need to find out what the Federal regs were for 
scheduled drugs and that an appropriate method for paying for this needed to be found. 
 
Marci Sorg, from the Margaret Chase Smith Center, was involved in the drug 
mortality/morbidity studies recently and works with the state medical examiner.  She has 
seen the results of a lot of mistakes, especially in the elderly. 
 2 
 
Ann Robinson, representing Pharma, noted that diversion is an issue with today’s 
children, stressing that drugs ought to be taken by those to whom they were prescribed.  
The science issues are complex and emerging with lots to be learned.  She advised the 
group to proceed with caution. 
 
Jim Cameron from the Maine Attorney General’s Office is concerned about diversion, 
noting that Schedule II drugs have a huge street value.  A collection mechanism must 
keep this in mind.  Security must be built in. 
 
Pharmacies, represented by both Jim MacGregor of the Maine Merchants Association, 
and Bob Morisette, noted that reverse distribution is a common practice. 
 
Current Practices 
 
Scott Austin noted that there are some current requirements, including RCRA, which 
controls toxic drugs (chemotherapy, etc) and the DEA, which dictates controlled drug 
disposal.  He noted the need to involve the State Board of Pharmacy.  The Maine 
Hospital Association has identified alternatives to incineration.  Scott noted that there 
would be some pollution concerns.  Steam sterilization is a cleaner non- incineration 
option for waste but not for drugs.   
 
It was noted that law enforcement incinerates at 1800 degrees.  They incinerate evidence, 
both pills and marijuana, totaling 9.1 tons per year.  This is mostly marijuana.  It was also 
noted that chemo drugs cannot be incinerated. 
 
Ann Pistell noted that the USGS has identified pharmaceuticals in the water.  The EPA is 
doing a sampling and we should have results by the end of the month. 
 
Suggestions for Legislation  
 
Dr. Gressit told the group that the DEA has said that controlled drugs cannot be returned 
to pharmacies and other providers.  Apparently specific licensed individuals cannot 
handle these as returns.  He suggested a mail-back program where a packet would go to 
the post office and the DEA could empty the box and dispose of the contents 
appropriately. 
 
Ann Pistell suggested considering product stewardship.  The returns could go back to the 
pharmaceuticals, similar to the mercury switch law.  She also suggested that perhaps they 
could be handled as hazardous waste and be collected as such.  The group discussed this 
but concerns over the safety of handling the drugs were prevalent. 
 
Marci Sorg cautioned the group to consider HIPPA issues. 
 
Senator Bromley threw out the idea of doing a pilot program with one drug but the idea 
was dismissed.  All prescription drugs would be preferable. 
 3 
 
The group agreed that incineration would be worth pursuing.  However, the “air people” 
at DEP need to be able to weigh in on this.  Extra manpower and resources would be 
needed for this.  Having the DEA incinerate would satisfy the licensing question. 
 
The DEP suggested that Maine needs better waste control treatment plants, which should 
be the subject of a separate bill. 
 
Roy McInney of the MDEA had a number of comments.  1) From a public safety 
standpoint, the MDEA would like to be of assistance, as long as it does not endanger its 
core mission, which is to reduce the drug supply through identification and prosecution of 
drug traffickers. 2) MDEA has a central evidence facility, which has 5000 individual 
exhibits collected each year.  They dispose of these through incineration.  Approx 9 tons 
were destroyed last year. 3) We must find funding for using MDEA’s infrastructure.  It’s 
$88/ton for destruction.  And the cost of staff needs to be covered.  They would need two 
people and a vehicle to do this.   Roy was interested in finding out how much volume 
we’re expecting but this number was too hard to discern (somewhere between 5000 and 
10000 pounds was suggested). 
 
The public health nurse asked the group what they thought of including veterinarian 
medications.  The group seemed interested and agreed to include them. 
 
Focusing the Legislation 
 
Senator Bromley suggested that the legislation be a pilot program.  Marci Sorg was 
solicited to suggest particular counties where diversion was the worst and she 
recommended Cumberland and Washington.  However, Anna Bragdon suggested that we 
ask for a statewide program and only reduce it to a pilot program if need be. 
 
Dr. Gressit suggested using school districts to distribute information and mailers. 
 
Marci Sorg suggested that there may be federal dollars and money from drug 
manufacturers.  Jim Cameron noted that the manufacturers have foundations.  We would 
need to determine how we would use the money before we asked.  It’s important to have 
no strings attached.  He suggested Purdue Pharma and Phizer. 
 
It was suggested that we poll the state for current disposal behaviors.  There is a 
statewide survey already done which we could add a question to for a fee.  It is sent to 
4000 Maine residents. 
 
The group discussed doing a random opening of 100 packages to learn from them.  We 
could translate found pills into actual dollars.  The Poison Center could do the research 
on the pills with some staff help.  There may be privacy issues that need to be addressed. 
 
 
 
 4 
Issues needing further attention 
 
Postal inspectors  
Liquids 
Committee referral – HHS 
Mobilization of support (including AARP) 
Research aspect 
Rules should be minor technical. 
 
Conclusion 
 
Senator Bromley wrapped up the meeting by reviewing the group’s progress.  A bill will 
be drafted which will call for mailers for returned prescriptions to be destroyed by the 
MDEA.  It will include veterinary meds and the rules will not be major substantive. 
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Northern New England Poison Center 
Medication Disposal Summary Report 
Latest update (1/17/2008) 
 
Purpose 
The purpose of this report is to: 
• Summarize research related to, and the controversy surrounding, medication disposal. 
• Document rationale for the Northern New England Poison Center’s (NNEPC) 
Medication Disposal Recommendation.  
 
Executive Summary 
Medication-related overdoses have increased significantly in recent years.1  Limiting access to 
medicines is a key prevention strategy (“clean out the medicine cabinet”).2 
 
Pharmaceuticals and other personal care products (PPCP) have been found in our water 
supply.3 The sources are most likely excrement, flushed products and ground water 
contamination from land-fills.4, 5, 6, 7  The presence of PPCP in the environment has not been 
proven to negatively affect humans.  However, the health effects from long-term exposure to 
these compounds are not clear.8 
 
There is controversy about how to properly dispose of medicines (Table 1 & 2).9  There are 
three common methods utilized throughout the United States for medication disposal: flushing, 
throwing away and collecting5,10,11 All of these options have strengths and weaknesses. 
Legislation related to medication reuse and disposal varies by state. The goal of any disposal 
method needs to keep these in mind: 
? Prevent acute poisoning; 
? Prevent abuse; 
? Ensure patient safety; 
? Limit environmental impact and water supply contamination.  
 
Ultimately, any disposal recommendation needs to be practical, cost effective and safe. The 
NNEPC is taking an active role in developing disposal recommendations for the general public 
and health care and public health professionals.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   2 of 6 
 
 
Call to Action 
In 2006 the American Medical Association (AMA) passed a resolution asking the United States 
Environmental Protection Agency (EPA) to lead the nation in addressing this issue. The AMA 
requested that the EPA: 
1. Continue aggressive research to understand the public health impact of PPCP’s on the 
drinking water supply, environment and human health. 
2. Lead and engage stakeholders from other federal agencies, the pharmaceutical 
industry, hospitals and other health care institutions, health professional organizations 
representing physicians, pharmacists, and nurses and the public for the proper disposal 
of PPCP to prevent drinking water contamination and environmental impact.12   
 
Medicine-Related Poisonings 
Childhood poisonings - In 2005, in the United States, more than a half-million calls were made 
to poison centers about medication-related poisonings among children 5 years of age and 
younger.13 
Medication overdoses - In 2004, poisoning became the second leading cause of death from 
unintentional injury in the United States.  According to the Centers for Disease Control and 
Prevention, nearly all poisoning deaths in the United States are attributed to drugs, and most 
drug poisonings result from the abuse of prescription or illegal drugs.1  Several reports confirm 
this alarming trend of pharmaceutical abuse and misuse.14,15,16,17,18   
 
Pharmaceuticals and Personal Care Products (PPCP) in the Water Supply 
Medicines are not entirely absorbed by our bodies, and are excreted and passed into 
wastewater and surface water.  According to the Environmental Protection Agency, studies 
have shown that pharmaceuticals are present in our nation’s waterbodies.3-7  Research 
suggests that certain drugs may cause harm to the environment.  To date, scientists have not 
found evidence of adverse human health effects from PPCP’s in the environment.8 
Medications’ effects on the aquatic environment:  
• Ability to resist degradation in the aquatic environment; 
• Accumulation in adipose tissue of aquatic organisms;  
• Potential to poison aquatic organisms.19 
 
It is important to remember, “Not everything that counts can be counted and not everything 
that can be counted counts.” – Albert Einstein20 
 
Medication Disposal Recommendations 
There is no undisputed recommendation for disposing of medicines (Table 1 & 2).  There are 
three common methods utilized throughout the United States for medication disposal: flushing, 
throwing away and collecting for incineration.  Community-based studies show that most 
people dispose of unwanted medicines in their garbage or by flushing them down their toilets 
or sinks, but would be willing and interested in properly disposing of their unused or expired 
medicines by returning them to a convenient location (such as a pharmacy).5, 9-11,21,22 
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Table 1. Comparison of Medication Disposal Recommendations 
 
Strength 
Take-back 
incineration 
programs 
Pharmacy 
take-back 
programs 
Hazardous 
waste 
management
Throwing 
away 
medicines 
in the 
garbage 
Flushing 
medicine 
down the 
sink or 
toilet 
Prevents children and pets 
from unintentional 
poisonings 
√ √ √   √ 
Prevents drug users access 
to medicines √ √ √   √ 
Low impact on the 
environment √         
Relatively inexpensive for 
the participants and 
communities 
    √ √ 
Population in support √ √ √     
Convenient       √ √ 
Weakness 
Take-back 
incineration 
programs 
Pharmacy 
take-back 
programs 
Hazardous 
waste 
management
Throwing 
away 
medicines 
in the 
garbage 
Flushing 
medicine 
down the 
sink or 
toilet 
Costly √  √ √      
Inconvenient for 
participants √ √ √     
Not available in all 
communities √ √ √     
Where available, it is 
infrequent and may lead to 
hording (e.g., storing of 
medicines for once a year 
disposal could lead to 
poisonings or drug 
diversion) 
√   √     
Inconsistent disposal 
practices among 
pharmacies 
  √**       
Potential risk of 
unintentional poisonings of 
children and pets 
      √   
Potential risk of access to 
medicines for drug users       √   
Increases the amount of 
medication in our water 
supply and environment 
  √**   √** √**  √ 
Not allowed to accept 
controlled substances √^  √^ √     
 
** This may lead to an increase in the water supply, depending on how material is discarded.  
^ Depends on state laws and regulations. 
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Table 2. Various Agency Recommendations 
 
Federal Agency Medication Disposal Recommendation Website 
American 
Pharmacists 
Association 
US Fish and Wildlife 
Services 
Crush solid medications or dissolve them in water (this applies for 
liquid medications as well) and mix with kitty litter or sawdust (or 
any material that absorbs the dissolved medication and makes it 
less appealing for pets or children to eat), then place in a sealed 
plastic bag BEFORE tossing in the trash.  
Remove and destroy ALL identifying personal information 
(prescription label) from the medication container.  
Check for approved state and local collection programs or with 
area hazardous waste facilities.  In certain states, you may be able 
to take your unused medications to your community pharmacy. 
http://www.pharma
cist.com/AM/Temp
late.cfm?Section=
Public_Health2&T
emplate=/CM/HTM
LDisplay.cfm&Con
tentID=11650  
Environmental 
Protection Agency 
Department of Health 
and Human Services 
American Medical 
Association 
Office of National 
Drug Control Policy 
? Take unused, unneeded, or expired prescription drugs out 
of their original containers and throw them in the trash. 
? Mix prescription drugs with an undesirable substance, 
such as used coffee grounds or kitty litter, and putting 
them in impermeable, non-descript containers, such as 
empty cans or sealable bags, will further ensure the drugs 
are not diverted. 
? Flush prescription drugs down the toilet only if the label or 
accompanying patient information specifically instructs 
doing so. 
? Take advantage of community pharmaceutical take-back 
programs that allow the public to bring unused drugs to a 
central location for proper disposal. Some communities 
have pharmaceutical take-back programs or community 
solid-waste programs that allow the public to bring unused 
drugs to a central location for proper disposal. Where 
these exist, they are a good way to dispose of unused 
pharmaceuticals. 
http://whitehousedr
ugpolicy.gov/drugf
act/factsht/proper_
disposal.html 
 
 
 
http://jama.ama-
assn.org/cgi/conte
nt/full/297/12/1307
-a 
Substance Abuse 
and Mental Health 
Services 
Administration 
• Mix unused drugs with coffee grounds, kitty litter, or another 
undesirable substance and place in a sealed container before 
disposing in the trash. 
• Prescription drugs should not be flushed down the toilet unless 
specifically instructed to do so. 
• Where community prescription drug take-back programs exist, 
they are a good way to dispose of unused pharmaceuticals. 
http://www.samhsa
.gov/rxsafety/SAM
HSA3tagged.pdf 
Food and Drug 
Administration 
Throw away expired medicines at a home hazardous waste 
disposal site or in a garbage can away from small children and 
pets.  
http://www.fda.gov
/medsinmyhome/M
IMH_as_they_gro
w.htm 
Centers for Disease 
Control Return to the pharmacy 
http://www2a.cdc.g
ov/podcasts/media
/pdf/EID%20Podca
st%2010-18-
06%20Antimicrobi
als%20Transcript.
pdf 
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American Association 
of Poison Control 
Centers 
Under review www.aapcc.org 
 
 
 
Continue Table 2.  
 
State Agency Medication Disposal Recommendation Website 
Maine Department of 
Environmental Services 
Maine Department of Health 
and Human Services 
A. Voluntary Turn-In Events 
B. Mail-In Program 
C. Product Stewardship 
D. Legislation to Consider Redistribution 
 
http://www.umain
e.edu/mainecent
eronaging/docum
ents/globalperspe
ctives.pdf 
Maine Pharmacy Association Under review www.mparx.com  
      
New Hampshire Department 
of Environmental Services 
Contact your local household hazardous waste 
coordinator prior to a collection event to determine if your 
municipality will accept the waste. Most collection events 
will accept mercury-added or other personal care 
products, but not pharmaceutical waste.  
Dispose of the waste in household trash.  
Keep products in their original containers. Pharmaceutical 
container caps are typically watertight and child proof.  
Add a small amount of water to a solid drug or some 
absorbent material such as kitty litter, sawdust or flour, to 
liquid drugs before recapping to discourage any 
unintended use of the drug.  
Double seal the container in another container or heavy 
bag to prevent easy identification of the drug container  
http://www.des.st
ate.nh.us/factshe
ets/sw/sw-33.htm 
 
New Hampshire Department 
of Health and Human 
Services 
New Hampshire Pharmacy 
Association 
 
Crush solid medications or dissolve them in water (this 
applies for liquid medications as well) and mix with kitty 
litter or sawdust (or any material that absorbs the 
dissolved medication and makes it less appealing for pets 
or children to eat), then place in a sealed plastic bag 
BEFORE tossing in the trash.  
Remove and destroy ALL identifying personal information 
(prescription label) from the medication container. 
 
 
http://whitehouse
drugpolicy.gov/ne
ws/press07/0220
07.html  
   
Vermont Department of 
Health 
• Take unused, unneeded or expired prescription 
and over-the-counter drugs out of their original 
containers.  
• Mix the prescription drugs with an undesirable 
substance (for example, used kitty litter, coffee 
grounds, bacon fat, soil), place the mixture into a 
http://healthverm
ont.gov/adap/ada
p.aspx 
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sealable plastic bag or container, and place it into 
the trash.  
• When discarding a transdermal patch, fold the 
patch into itself and then place it in the 
undesirable mixture. 
 
Vermont Pharmacy 
Association Under review 
www.vtpharmacis
t.org 
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Stevan Gressitt, M.D., Medical Director 
Office of Adult Mental Health Services 
Department of Health and Human Services 
Marquardt Building, 2nd Floor 
11 State House Station 
32 Blossom Lane 
Augusta, ME  04333-0011 
Ph: (207)287-4273 
Fax: (207)287-1022 
Cell Phone: (207) 441-0291 
E-Mail : stevan.gressitt@maine.gov 
http://www.maine.gov/dhhs/mh/ 
  
Confidentiality Notice: This e-mail message, including any attachments, is for the sole use of the intended recipient(s).  It may contain confidential and privileged
information.  Any unauthorized review, copy, use, disclosure, or distribution is prohibited.  If you are not the intended recipient, please note that any
dissemination, distribution or copying of this is strictly prohibited.  Please contact me by reply e-mail or telephone and destroy all copies of this message. 
The Department of Health and Human Services (DHHS) does not discriminate on the basis of disability, race, color, creed, gender, sexual orientation, age, or
national origin, in admission to, access to, or operations of its programs, services, or activities, or its hiring or employment practices.  This notice is provided as
required by Title II of the Americans with Disabilities Act of 1990 and in accordance with the Civil Rights Act of 1964 as amended, Section 504 of the
Rehabilitation Act of 1973, as amended, the Age Discrimination Act of 1975, Title IX of the Education Amendments of 1972 and the Maine Human Rights Act
and Executive Order Regarding State of Maine Contracts for Services.  Questions, concerns, complaints or requests for additional information regarding the ADA
may be forwarded to DHHS’ ADA Compliance/EEO Coordinators, 11 SHS-221 State Street, Augusta, Maine 04333, 207-287-4289 (V), 207-287-3488 (V), 1-800-
606-0215 (TTY).   
  
  
From: provider-bounces@informe.org [mailto:provider-bounces@informe.org] On Behalf Of Provider Notification 
Sent: Friday, July 31, 2009 3:59 PM 
To: List Serve  
Subject: [Provider] 15-day limit on first-time prescriptions for certaindrugs 
  
MaineCare has begun instituting measures to ensure cost effectiveness through the use of Drug Benefit 
Management, Drug-Drug editing to ensure education and patient safety, recent PPI limitations and Intensive 
Benefit Management with controlled substances.  
  
For a number of years in Maine, research from the Maine Benzodiazepine Study Group, The University of Maine 
Center on Aging, and in part funded by the only Federal Grant in the US on unused drug return mail back 
programming has suggested that adherence to medication and other variables may lead to large amounts of 
unused and discarded medication. Closer evaluation of side effects and efficacy may lead to better patient 
outcome and better safety for patients with closer evaluation of initial response. 
  
With that, MaineCare will institute new 15 day limits on initial prescriptions for various medication that have 
been identified with high side effect profiles, high discontinuation rates, or frequent dose adjustments to ensure 
cost effectiveness without “wasting” or “discarding” of used medications.  Effective 8/6/09 MaineCare will begin 
limiting initial prescriptions on the following medications, Suboxone, Subutex, Chantix and Nicotine replacement 
products to 15 day supplies. Initial prescriptions for preferred products over the initial 15 day supply will require 
prior authorization. Subsequent refills of these products will be allowed at the usual MaineCare allowable days 
supply. 
  
For further questions please contact Goold Health Systems at 1-888-4450497. 
  
Is your mailing address up to date with MaineCare?  Please keep MaineCare up to date so your Remittance Statements 
and checks arrive on time.  Call Provider Enrollment at 1-800-321-5557 Option #6.   
  
If you would rather not get these e-mails, visit MaineCare's List Serve Subscription page to unsubscribe. 
  
This is a one-way communication.  Do not reply to this e-mail.  Your e-mail will not receive response.  If you have questions, 
please call 1-800-321-5557.   
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THE ATHENS DECLARATION as unanimously voted on August 3rd, 
2007 at the 2nd International Conference on Environment in the City 
of Athens Cultural Center is as follows: 
 
We, an international group, support the following six reasons to address citizen unused 
drug disposal: 
 
1. To curtail childhood overdoses 
2. To restrict household drug theft 
3. To limit accumulation of drugs by the elderly 
4. To protect our physical environment 
5. To restrain improper international drug donations 
6. To eliminate waste in the international health care systems of all countries  
 
We call upon governments, NGO's, and citizens everywhere to correct policies and 
practices that foster waste in the health care systems of all countries and endanger 
humans, animals, and our physical environment. 
 
We call upon all countries to renew their support of WHO Guidelines on Drug Donations 
and the WHO Guidelines on Drug Disposal, and strive to improve on these. 
 
We call upon health care providers worldwide to appropriately prescribe medicines to 
patients in the most effective form and quantity. 
 
We call upon health care organizations to refrain from policies that promote excessive 
dispensing. 
 
We call upon patients worldwide to recognize the need for medicine to be taken as 
intended if it is to be effective. 
 
We call upon governments, NGO's, and citizens worldwide to refrain immediately from 
improper drug donations either as humanitarian aid following disasters or in general 
practice. 
 
We call upon others to endorse these principles with us for the betterment of the health 
of the environment and patients worldwide. 
 
Athens, 
Greece 
August 3rd, 
2007 
 
In North America: 
Maine Benzodiazepine Study 
Group 
Stevan Gressitt, M.D. 
207-441-0291 
Gressitt@uninets.net 
www.mainebenzo.org
 
 Whereas inattention to prescribing policy, reimbursement incentives, formulary 
selection, distribution, pricing systems, dispensing and actual prescription writing, have 
led to the need for this Istanbul Statement of September 7, 2009 during the 69th 
Conference of FIP. Confirming the Athens Declaration of 2007, this Statement as well 
draws attention to responses to these problems in the Netherlands, Sweden, and the 
State of Maine in the United States of America. Research from a number of countries as 
diverse as Canada and Kuwait demonstrate the need for further work and research but 
already a need for addressing the problem. 
               We thereby ask that all NGO's, governmental bodies, health care professionals, 
pharmaceutical manufacturers, and citizens everywhere place unused drug disposal 
and prevention of pharmaceutical waste as a highest priority. We encourage those 
listed above to move to address this problem as soon as possible. 
  
Istanbul, Turkey 
September 7, 2009 
Stevan Gressitt, M.D. 
 
Rationale for a Concerted Focus on Unused 
Pharmaceuticals 
Ilene S. Ruhoy, MD 
Doctoral Candidate 
University of Nevada, Las Vegas 
Department of Environmental Studies 
Stevan Gressitt, MD 
Maine Benzodiazepine Study Group, The Drug Disposal Group,  
Medical Director, Northeast Occupational Exchange, 
Corresponding Author: 314 Clark Road, Unity, Maine, 04988 207-441-0291 
gressitt@uninets.net  
Abstract: 
 Unused and unwanted consumer pharmaceuticals have a negative impact on 
public health. The lack of effective and efficient methods of drug disposal has resulted in 
unwelcome social, cultural, ecological, and global effects.  
Among the many issues pertinent to unused consumer medication, we have 
comprehensively explored and addressed six specific and significant problems; 
1) Childhood Poisoning: Unintentional pharmaceutical poisonings of children, 
resulting in unnecessary morbidity and mortality. 
2) "Pharming": Theft and social use, misuse, and abuse of pharmaceuticals by 
teenagers, adults, and older adults.  
3) Excessive Accumulation and Polypharmacy: Polypharmacy, non-compliance 
and/or poor adherence to medication regimens, and medication errors 
contributes to accumulation and poor patient outcome.  
4) Unintended Environmental Exposure: Potential deleterious effects on wildlife and 
humans due to drug deposition in surface and ground waters as a result of 
both disposal and excretion pathways.  
5) Inappropriate Humanitarian Drug Donations: Under-regulated and poorly 
controlled methods of international donations to countries in need, resulting in 
massive amounts of “gifts” of unused and expired pharmaceuticals. Expired 
and unwanted drugs ultimately become accumulated waste, some of which 
may be hazardous, due in part to the lack of an environmentally sound 
disposal or destruction method.  
6) Pharmacoeconomics: Unused medications contribute to wasted health care 
dollars. The purchase costs of drugs to the consumer, the insurance carrier, and 
the taxpayer have continued to increase in the past decade.  
 
These issues define the problem of proper disposal of unused pharmaceuticals 
and beg for acceptable solutions to protect human and environmental health. 
  
  
FOR IMMEDIATE RELEASE 
April 8, 2010  
Contact:  Darlene Casey
(O) 202-268-3440 
darlene.casey@usps.gov 
usps.com/news 
Release No. 10-032
 
Postal Service Expands Prescription Mail Back 
Program Diverts Expired, Unused Medicine from Landfills, Water Supply 
 
WASHINGTON — Veterans will be able to safely dispose of expired and unused prescriptions and help the 
environment at the same time under a program offered by the U.S. Postal Service and U.S. Department of 
Veterans Affairs (VA). 
 
This pilot program is limited to an estimated 780,000 veterans living in Baltimore, Washington, DC, and West 
Virginia. Veterans mail back outdated, unwanted medicine. Federally approved facilities safely destroy the 
medicine, insuring that prescriptions don’t end up in municipal refuse, soil or ground water.  
 
“This initiative pairs the convenience of the mail with the safety of a federally approved prescription drug 
disposal process,” said Robert Bernstock, president, Mailing and Shipping Services. “The Prescription Mail 
Back program demonstrates the Postal Service’s continued value as an integral part of American 
communities.” 
 
Veterans receive specially designed, postage-paid envelopes and instructions with their prescription 
fulfillment. Expired and unused pharmaceuticals placed in the special packaging can be dropped in familiar 
blue USPS collection boxes or at Post Offices. The envelopes are delivered to facilities regulated and 
approved by the Environmental Protection Agency (EPA) and Drug Enforcement Agency (DEA). 
Pharmaceuticals from this and other similar mail-back initiatives are destroyed in accordance with EPA and 
DEA standards, including cataloguing and use of incineration, chemical or thermal processes. 
 
The prescription mail-back initiative began in the state of Maine in 2008, and has been successfully 
expanding ever since. The VA program joins similar ones in 47 states. Mail-back envelopes are being 
distributed at supermarket pharmacies, in doctors and dentists offices, and at medical facilities including 
hospitals, clinics and hospices. 
 
“The 40th anniversary of Earth Day is a perfect opportunity to tell Americans the good news about the 
expanded prescription mail-back program,” said Sam Pulcrano, vice president, Sustainability. “It is another 
way the Postal Service demonstrates its commitment to the environment.” 
 
The Postal Service has won more than 75 environmental awards, including 40 White House Closing the 
Circle, 10 Environmental Protection Agency WasteWise Partner of the Year, Climate Action Champion, Direct 
Marketing Association Green Echo, and the Postal Technology International Environmental Achievement of 
the Year, 2009. 
 
For more information about the Postal Service green initiatives, tools and products, visit usps.com/green. 
 
The Postal Service receives no tax dollars for operating expenses, and relies on the sale of postage, 
products and services to fund its operations. 
# # # 
Please Note: For broadcast quality video and audio, photo stills and other media resources, visit the USPS Newsroom at 
www.usps.com/news. 
 
A self-supporting government enterprise, the U.S. Postal Service is the only delivery service that reaches every address in the nation, 
150 million residences, businesses and Post Office Boxes. The Postal Service receives no direct support from taxpayers. With 36,000 
retail locations and the most frequently visited website in the federal government, the Postal Service relies on the sale of postage, 
products and services to pay for operating expenses. Named the Most Trusted Government Agency five consecutive years and 
the sixth Most Trusted Business in the nation by the Ponemon Institute, the Postal Service has annual revenue of more than $68 billion 
and delivers nearly half the world’s mail. If it were a private sector company, the U.S. Postal Service would rank 28th in the 2009 Fortune 
500. 
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Phase II Area Agency on Aging Recruitment Letter 
 
 
 
October 1, 2008 
 
 
Dear AAA Director,  
 
The Safe Medicine Disposal for ME Program is a program that provides postage-paid envelopes 
to Maine residents for safe disposal of unused and unwanted medicine. During the past year, the 
Safe Medicine Disposal for ME Program has been working to establish pilot program sites 
within a designated four-county area. The program has become such a success within our pilot 
pharmacy sites that we are now expanding the program statewide. Our first key step is to secure 
partnering distribution sites across the state that are interested in providing Maine residents with 
pre-paid envelopes for medicine disposal.  
 
We would like to extend an invitation for your organization to join a growing roster of 
organizations that are participating as a distribution site for envelopes. As an Area Agency on 
Aging, you and your staff members represent a critical link to older adults throughout the state. 
Research indicates that older adults consume far more prescription drugs than any other 
population, putting them at risk for accumulation of medication that is unneeded and unwanted.  
 
Please consider joining our program as a distribution site. Here is what is required of distribution 
sites:  
 
o There is no cost to you or to program participants (this is currently a grant-funded program). 
 
o A designated staff person at your location should provide program envelopes to all interested 
individuals at no cost to them.  
 
o You will be asked to display a sign or flyer at your location alerting the public to the 
availability of program envelopes.  
 
o You and your staff do not need to answer any questions about the program. We have an 
established Program Helpline for participants.  
 
We anticipate that envelopes will be available for distribution within the next few months.  
Please confirm that your organization is interested in participating in the program. If you are 
interested in serving as a site, please complete the attached contact information sheet to ensure 
that we have up to date contact information for you and your site. Return this form to me by e-
mail at: jennifer.crittenden@umit.maine.edu or by fax at 207-262-7921. You can expect to 
receive regular updates on the program as we gear up to go statewide.  
 
Thank you for considering partnering with our program. We hope that you will consider serving 
as a site for this very important project benefiting Maine residents. Please do not hesitate to 
contact me with any questions you may have.  
 
 
Sincerely,  
 
 
 
Lenard Kaye, DSW/Ph.D. 
Principal Investigator 
 
 
 
 
 
Jennifer Crittenden 
Program Director 
 
Safe Medicine Disposal for ME Program 
 
 
 
 
March 16, 2010 
 
To: Safe Medicine Disposal for ME Site Contacts 
 
From: Jennifer Crittenden, Program Director 
 
RE: Welcome to the Safe Medicine Disposal for ME Program! 
 
On behalf of the Safe Medicine Disposal for ME Program, we would like to welcome 
your organization to our growing list of statewide mailback program sites. Our program 
originally began in the spring of 2008 and was geared toward older adults. It has become 
such a success that we are now expanding statewide and opening the program to all ages 
(no longer just for older adults). We expect to be fully operational statewide by the end of 
November.  
 
Please take a moment to review the items in your welcome folder. These items include a 
Procedure Guide, Question and Answer Guide, Detailed Fact Sheet, Program Site Listing, 
Consumer Fact Sheet and a copy of the Memorandum of Understanding (MOU).  
 
Along with the envelopes that have been provided to you, you will find a program sign 
for display at your site along with consumer education materials related to the program. 
Feel free to distribute these items as you see fit.  
 
Welcome to the program and please feel free to contact the helpline with any general 
questions or concerns you may have at 1-866-637-9743.  
 
Thank you for your commitment to health and safety of Maine’s citizens. 
 
 
Sincerely,  
 
Jennifer Crittenden 
Program Director 
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Safe Medicine Disposal for ME Program 
 
 
 
 
 
March 16, 2010 
 
Dear NAME HERE,  
Thank you for agreeing to participate in the next phase of  the Safe Medicine 
Disposal for ME program.   
 
We will arrange for shipment of  program envelopes and a welcome packet 
directly to the address we have on file for your site. We anticipate that these will 
be delivered to you in November.  
 
Enclosed, you will find a copy of  the program MOU.  It outlines the basic 
concepts and expectations of  the program.  Please sign this form and send it 
back to the Center on Aging for our files either by mail at UMaine Center on 
Aging, ATTN: Lynette Roy, Camden Hall, 25 Texas Ave., Bangor, Maine 04401 
or by fax at 207-292-7921. Once we have this on file we will be able to arrange 
for your envelope shipment.  
 
Once again, welcome on board, and please feel free to contact the helpline with 
questions or concerns at 1-866-637-9743. 
 
 
Sincerely,  
 
Jennifer Crittenden 
Program Director 
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SAFE MEDICINE DISPOSAL FOR ME PROGRAM 
 
MEMORANDUM OF UNDERSTANDING 
(WITH PARTICIPATING SITES) 
 
This Memorandum of Understanding (MOU) contains basic provisions which guide the 
working relationship between both parties.  This MOU may be amended, in writing, at any 
time with the concurrence of both parties and may be renegotiated at the end of Phase II of 
the program. 
 
PROVISIONS OF THE MEMORANDUM OF UNDERSTANDING 
 
Safe Drug Disposal for ME Program: 
 
• The Program will arrange for drug return envelopes and materials to be mailed to your 
site or corporate location. 
 
• The Safe Medicine Disposal for ME Program will have a hotline number for site 
personnel and the public to call in order to ask questions or voice concerns.  This is a 
voice mail system staffed by the University of Maine Center on Aging.  Messages will be 
returned within 2 business days. 
 
• The Program will promote to the public all Phase II participating sites. Marketing 
materials will include, when possible, the name of the participating pharmacy or site, the 
physical location of the site, and the site telephone number.  
 
• There is no charge to sites or community members to participate. 
 
Participating Sites: 
 
• All signage must be placed for the public to see, such as on the sales counter, in order to 
indicate that project envelopes are available.  Supplies of program brochures, consumer 
fact sheets and business cards will be available for sites to distribute. 
 
• Envelopes are not to be provided to group homes, nursing homes, or other facilities for 
their use. The Safe Medicine Disposal for ME Program is only available to individual 
citizens at this time.   
 
• Envelopes are to be given free of charge to all who ask. No purchase is necessary. 
 
• Sites are not expected to answer questions regarding the program.  Business cards with 
program hotline contact information will be available for customers seeking further 
information. 
 
• Sites are expected to use the program hotline if any questions or concerns should arise. 
 
• Sites agree to provide information on a regular basis concerning the number of envelopes 
available when contacted by program staff. 
 
• Sites agree to proactively provide customers with drug return envelopes in order to 
promote the program. This program is open to adults of all ages. 
 
By signing and dating this Memorandum of Understanding, I acknowledge that I have read 
and understand the above stated provisions, and agree to adhere to them as closely as 
possible.  I also agree that I am the primary contact for my site for all future communication 
with the Safe Medicine Disposal for ME Program. 
 
 
SITE CONTACT PERSON SIGNATURE: ____________________________________    DATE: __________ 
 
SITE CONTACT PERSON (PRINT NAME):___________________________________ 
 
 
PROGRAM STAFF MEMBER SIGNATURE: _________________________________    DATE: __________ 
 
PROGRAM STAFF MEMBER (PRINT NAME):________________________________ 
 Is
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 If you have unused or expired medicine 
in your home, you may be at risk of… 
 
 Theft of medicine by drug abusers 
 
 Poisoning of loved ones and pets 
 
 Taking expired or wrong medicine 
 
 Polluting your environment 
 
Make your home safe by getting rid of 
unwanted or expired medication though the 
Safe Medicine Disposal for ME Program. 
 
Free postage-paid 
medicine return 
envelopes available 
here for all Maine 
residents.  
Ask a staff member for more  
information. 
Safe Medicine Disposal for ME Program 
 
What will I be asked to do? 
Please ask your customers or clients if they would like an envelope to safely dispose of unused 
or expired medicine in their home. If they are interested, give them an envelope with a survey 
and directions inside. Please provide envelopes to anyone who asks for one. No purchase is 
required and there is no cost to participate.  
 
Who should get the envelopes? 
When the program first began, it was specifically designed for older adults. However, the need 
for safe medicine disposal affects many age groups. In response to this need, the program is 
now designed for adults of all ages. The envelopes are for individual or family use only, 
and are not intended for nursing homes, groups homes or other large group returns.  
 
What about participants who want more than one envelope? 
Participants may use more than one envelope. Please use your judgment when handing out 
multiple envelopes. Supplies are limited. Once you run out of envelopes we cannot guarantee 
that we can provide you with additional envelopes.  
 
How much does it cost? 
Nothing. There is no charge to the distribution sites or the participants for the postage-paid en-
velopes. Funding for this program was provided by the United States Environmental Protection 
Agency’s Aging Initiative. 
 
What do the participants do with the envelopes? 
They enclose all unwanted medicine according to the Instruction Booklet included in each     
envelope and mail the envelope just like any other letter or package. There is a Program 
Helpline (1-866-637-9743) they can call if they have any questions. 
 
Why are the envelopes numbered? 
This is a code number for tracking the envelopes. Participants will call the Program Helpline at 
1-866-637-9743 when they mail their envelope and leave only the code number and the date 
that it was mailed (not their name) on the recording. The code number helps us to know which 
envelopes to expect and how long they take to get to the Maine Drug Enforcement Agency for 
storage and disposal.  
 
 
PROGRAM QUESTION AND ANSWER GUIDE 
Safe Medicine Disposal for ME Program 
 
 
What is Safe Medicine Disposal for ME?  
Safe Medicine Disposal for ME is a program which provides an opportunity for 
Maine residents to safely dispose of unused or expired medicine by mail. 
Contact Information 
 
If you have questions, please do not hesitate to contact us by e-mail or phone:  
 
E-Mail at: info@safemeddisposal.com  
 
Program Helpline at:1-866-673-9743 
 
For more information about the program, visit:  
www.safemeddisposal.com  
 
 
 
 
Thank you for your participation and for your commitment to well-being of Maine’s         
residents and our environment! 
 
 
What if we run out of envelopes? 
Please contact the Program Helpline. Envelope supplies are limited and we cannot guarantee 
that we will have additional envelopes for your pharmacy or organization.  
 
Where does the medicine go? 
The envelopes are returned to the Maine Drug Enforcement Agency. The medicine is then     
cataloged and safely destroyed. 
 
What happens to the surveys? 
The confidential surveys are sent to the Maine Drug Enforcement Agency along with the medi-
cine where they are then forwarded on to the University of Maine Center on Aging. The Center 
will conduct an analysis to determine the types of medicine returned and the reasons for the 
medicine being returned. 
 
Will I be able to find out the results of this program? 
Information about the amount and type of medicine that was returned will be posted on the pro-
gram website as it becomes available.  
 
What if I have additional questions or concerns about this program? 
Please contact the Center on Aging (contact information below) with any questions or concerns 
you may have.  
 
 
 
Updated September 19, 2008 
© 2008 University of Maine Center on Aging 
 Program Updates  
Since the mailback program began we 
have collected over 700lbs of medicine, 
from over 1600 envelopes. About 10% of 
the returned medicine is controlled 
(narcotics).  
 
The program went statewide and opened 
to individuals of all ages (no longer just 
older adults) in November 2008.  We 
have over 100 distribution sites that 
include pharmacies, several police 
departments and agencies.  We also have 
several more potential sites on a waiting 
list.   
   
The Helpline remains active receiving 
messages from people who have mailed in 
envelopes, have questions about the 
program, and those who want to become a 
distribution site.  
 
Need more supplies? 
If you need more envelopes, signs, 
pamphlets, tip sheets or business cards 
please leave a message on the Helpline, the 
number is 1-866-637-9743.  
 
We are currently out of envelopes but are 
planning to get more in the coming 
months.  In the meantime we are putting 
sites on a resupply list to receive envelopes 
as soon as we get them. 
 
Community Volunteers 
We have several community volunteers 
trained on the Safe Medicine Disposal for 
ME Program. Volunteers are located in 
Aroostook, Hancock, Kennebec, Knox, 
Oxford, Penobscot, Piscataquis, and York 
counties. If you would like a volunteer to 
work with you on a disposal or 
education/outreach event please contact 
us and we can connect you with a 
volunteer in your area.  
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SITE NEWSLETTER (March 10, 2009) 
 
This newsletter is specifically designed for pharmacies, healthcare offices, 
police departments and community agencies that are distributing envelopes 
through the Safe Medicine Disposal for ME Program (mailback program) 
How to Contact us:
Helpline:  1-866-637-9743 
 
Website: 
www.safemeddisposal.com 
 
E-mail: 
info@safemeddisposal.com
What happens to the medicine 
that is returned? 
 All envelopes that are returned are 
inventoried by pharmacists and pharmacy 
techs. Medicine is then sorted for disposal 
(incineration). See page 2 for pictures.  
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 Continuing Education Opportunity: 
Save the Date! 
2009 International Symposium on 
Pharmaceuticals in the Home and 
Environment 
 
October 18-20, 2009 
Point Lookout Resort and Conference Center, 
Northport, Maine 
 
Continuing Education Units (CEUs) will be 
offered! 
For more information visit: 
www.mainebenzo.org/2009conference.htm 
 
Here are some interesting pictures 
from our inventory sessions:  
 
 
Cataloging in action 
 
 
This is just a small sample of 
what we have received 
 
 
Unfortunately we receive many 
bottles of unopened medicine 
representing thousands of 
wasted healthcare dollars. 
 
 
It is not uncommon to see older 
medicines like this bottle of 
Formaldehyde 
 
 
Medicine that is mixed 
together without a bottle as 
shown here creates challenges 
for sorting and identification. 
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Organization 
 
Can I participate in this program? 
The program is open to all individuals and families who have unused and unwanted medi-
cine in need of disposal. The envelopes are for individual or family use only, and are not 
intended for nursing homes, group homes, medical facilities, or other large group returns.  
 
How much does it cost? 
Nothing. There is no charge to the pharmacies distributing the envelopes or the partici-
pants returning medicine in the postage-paid envelopes. Funding for this program was    
provided by the United States Environmental Protection Agency’s Aging Initiative.  
 
Where can I get an envelope? 
A listing of participating locations throughout Maine is available online at 
www.safemeddisposal.com or you can e-mail info@safemeddisposal.com or call our 
helpline for assistance at 1-866-637-9743.  
 
Can you send me an envelope? 
We are able to, on a limited basis, mail envelopes directly to individuals who are unable to 
get to a participating pharmacy to obtain an envelope.  
 
Can I use more than one envelope? 
Yes, if all your medicine does not fit in one envelope you can use more than one envelope. 
Please fill out a survey for each envelope that you mail.  
 
Can I use my own envelope or box? 
No. Please only use the special envelopes provided by the program. They have been ap-
proved by the US Postal Service for this purpose. If all of your medicine cannot fit into one 
envelope, you may request additional envelopes from your nearest participating pharmacy 
or via the program helpline. 
What should I do with the envelope? 
Enclose your unwanted or expired medicine according to the directions in the booklet 
found in each envelope, then mail the envelope just like any other letter or package. You 
can mail both liquids and pills in the same envelope as long as you follow the instructions 
in the booklet provided. If you can’t find your instruction booklet, you can view a copy on 
the program website or we can send you one by mail.  
 
What medicine can I dispose of through this program? 
This program accepts most kinds of prescription and over the counter medicine. Please do 
not include more than a total of 4 ounces ( or 120mL) of liquids, creams, and/or gels. 
 
Is there any medicine that I can’t dispose of through this program? 
Yes, some specialized medicine requires the use of a manufacturer disposal program. 
Check the packaging or contact your pharmacist for more information. Absolutely no sy-
ringes, medical devices (such as blood sugar monitors, etc.), needles,epi-pens broken 
glass, or sharp objects of any kind can be included. Even if they are wrapped or packaged, 
they may not be included. Contact your doctor or pharmacist for disposal options for these 
items. 
NOT FOR DISTRIBUTION:  FOR USE BY PROJECT STAFF AND VOLUNTEERS ONLY 
Safe Medicine Disposal for ME: 
Staff and Volunteer Question and Answer Guide 
  
 
 
What is Safe Medicine 
Disposal for ME?  
Safe Medicine Disposal for 
ME is a program which pro-
vides an opportunity for indi-
viduals and families in Maine 
to safely dispose of unused or 
expired medicine by mail. 
 
What are the benefits of 
using this program? 
• Reduce the chances for 
medication errors. 
• Keep medicine away from 
children and pets. 
• Keep medicine away from 
people who might misuse 
it or steal it. 
• Dispose of medicine in a 
way that protects Maine’s 
environment. 
 
How can I get more 
information? 
For technical questions, 
please contact the University 
of Maine Center on Aging  
Program Helpline at:  
1-866-637-9743 
 
Or send an e-mail to: 
info@safemeddisposal.com  
 
For general information about 
the program, log on to:  
www.safemeddisposal.com  
Funding for this program was 
provided by the EPA Aging 
Initiative. 
 
Can I return medicine if it not in its original bottle? 
Yes. Returning medicine in its original bottle will make it easier for pharmacist to identify it. However, if you cannot return it 
in its original bottle, you can put in in a small container or zip lock bag before placing it in the envelope. Please write down 
the name of the medicine, the dose, and the number of pills originally prescribed, if you know it. 
 
Can I dispose of pet or veterinary medicine? 
Yes, if there is room in your envelope after enclosing any prescription medicine you want to dispose of, you may include 
pet or veterinary medicine. However, we recommend that you contact your local veterinary clinic, animal shelter, humane 
society, or animal rescue group to see if they are able to use this medicine. 
 
Can I dispose of over the counter medicine, herbal supplements, or vitamins? 
Yes, if there is room in your envelope after enclosing any prescription medicine you want to dispose of, you may include 
over the counter medicine, herbal supplements, or vitamins. 
 
Can I dispose of medicated patches? 
Yes. If the patches are not already in a wrapper, place them in a zip lock bag before placing them in the envelope. 
 
Can I dispose of inhalers? 
Yes, if there is room in your envelope after enclosing any other prescription medicine you want to dispose of, you may 
include inhalers. 
 
Will you be collecting information about me when I return my medicine?  
Program staff will not be collecting any personal information about you from the medicine bottles that is returned. If you 
wish, you may mark out personal information from the labels on your medicine bottles. Please do not mark over the name 
of the medicine or number of pills. We will be collecting information only about the medicine that is returned in general to 
better understand the amount and kind of medicine that is piling up in Maine medicine cabinets. Information that you pro-
vide on the survey will help us to understand this issue. The survey is confidential and you can skip any questions you do 
not wish to answer.   
 
Why are the envelopes numbered? 
This is a code number for tracking the envelopes. Please call the Program Helpline at 1-866-637-9743 when you mail 
your envelope and leave only the code number and the date that it was mailed (not your name) on the recording. The pro-
gram is confidential, and any information about the returned medicine will not be linked to personal information. The code 
number helps us to know which envelopes to expect and how long they take to get to the Maine Drug Enforcement 
Agency for storage and disposal.  
 
What if I mailed my envelope but forgot to write down the code number first? 
Call the Program Helpline at  1-866-637-9743 and provide the date that you mailed the envelope and simply state that you 
do you not know what the code number is.  
 
Where does the medicine go? 
The envelopes are returned to the Maine Drug Enforcement Agency. The medicine is then cataloged and safely           
destroyed. 
 
Do I need to fill out the survey in order to send in medicine?  
You do not need to fill out the survey in order to participate in the program. The survey is optional. We encourage you to 
consider providing a response to the survey because this research will help us to improve the program and to understand 
why medicine goes unused in Maine.  
 
 
 
What happens to the surveys? 
The confidential surveys are sent to the Maine Drug Enforcement Agency along with the medicine where they are then 
forwarded on to the University of Maine Center on Aging. The Center will conduct an analysis to determine the types of 
medicine returned and the reasons for the medicine being returned.  
 
Will I be able to find out the results of this program? 
Information about the amount and type of medicine that was returned is available at http://www.safemeddisposal.com/
Research.php. You can also request this information by e-mail at: info@safemeddisposal.com or by calling 1-866-637-
9743. 
 
I am a pharmacist. How can my pharmacy participate in the program?  
Please call the helpline at 1-866-637-9743 and leave a message indicating you would like to become a site. A staff mem-
ber will return your call and provide you with the paperwork necessary to become a site. As of April 2009 we are maintain-
ing a waiting list for interested sites but we anticipate new sites will be welcomed to the program in the summer of 2009.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Updated April 23, 2009 
© 2008 University of Maine Center on Aging 
 
APPENDIX GROUP 7 
Mailback Envelope Materials 
 
• APPENDIX Group 7: Participant Mailback Envelope Materials 
 
o APPENDIX 7A: Instruction booklet for preparing and returning 
medicine 
 
o APPENDIX 7B: Informed consent for consumer survey 
 
o APPENDIX 7C: Consumer survey  
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Safe Medicine  
Disposal for ME 
Program  
 
A program for all Maine  
residents! 
 
INSTRUCTION BOOKLET  
 
Information on how to  
prepare and return your 
medicine for proper disposal 
 
Helpline: 1-866-637-9743 
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Program Partners 
The program has been made possible by the 
following organizational partners:  
Please see back page for full listing of program partners 
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Mailing Your Envelope 
Mail the envelope as you would any other letter 
or package through the U.S. Mail. 
 
There are several choices available to you 
including:  
• Hand the envelope directly to your mail carrier, 
• Bring it directly to your local Post Office for 
mailing,  
• Place the envelope into a blue United States 
Postal Service mailbox at your local Post 
Office or other locations in your area, or 
• Place the envelope in your home mailbox.  
 
 
 
 
 
Thank you for participating in this program! If you 
have any further questions or comments about 
the program please call:  
1-866-637-9743 
 
Please keep this booklet for your records. 
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SAFE MEDICINE DISPOSAL FOR ME PAGE 1 
Safe Medicine Disposal for ME is adminis-
tered by the University of Maine Center on Aging 
and Safe Medicine for Maine in partnership with 
the Maine Drug Enforcement Agency, the Maine 
Department of Environmental Protection, the 
United States Postal Service, and many other or-
ganizations concerned about protecting the 
health and welfare of Maine’s citizens. Because 
our program partners are committed to your 
health and safety, you are invited to take part in 
this exciting new program. The program was cre-
ated to give Maine residents a safe disposal op-
tion for unused and unwanted medicine.  
By mailing back your unused medicines, you:  
⇒ Reduce your risk of taking medicine in error 
that may be harmful or cause interactions with 
other medicine 
⇒ Reduce wasted healthcare dollars by         
contributing to important research  
⇒ Dispose of your medicine in a way that       
protects Maine’s environment and prevents 
groundwater contamination 
⇒ Get unwanted medicine out of your home and 
away from people who may want to steal your 
medicine or take it illegally 
 
 
  The Safe Medicine Disposal for 
ME Program 
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If you have questions about what to put 
into the envelope, please call the  
 
Program Helpline at: 1-866-ME-RX-RID (1-866-
637-9743).  
Visit our website: www.SafeMedDisposal.com 
E-Mail: info@SafeMedDisposal.com 
 
Find the 5-digit code 
number in the bottom left 
hand corner of your 
envelope.  
 
 
Write it here and  
keep for your records:__ __ __ __ __ 
 
 
 
Complete the survey 
and place it in the 
envelope with your 
medicine.  
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Liquids, Gels, and Creams 
The total combined volume of all liquids, gels, 
and creams returned should be 4 ounces 
(about 120 ml) or less.  Please wrap each 
container of liquid, gel, or cream in a paper 
towel and place it in a zip-lock bag before 
placing them in the envelope with any other 
medicine. 
 
Once all your medicine is placed in the 
postage-paid envelope, complete the survey 
provided. Place your 
completed survey in the 
envelope and seal it. It is 
now ready to be mailed.  
Only a total of  4 oz (or 120ml) of liquids, gels, 
and creams total can be mailed back. Wrap 
them in paper towels, place them in a zip lock 
bag, and put it in the envelope. Be sure to seal 
the zip lock bag and envelope tightly.  
 
 
SAFE MEDICINE DISPOSAL FOR ME PAGE 2 
Telephone Scams and Frauds 
Where will my medicine go?  
All medicine that you place in the pre-paid 
envelope provided will be sent to the Maine Drug 
Enforcement Agency for proper disposal.  
 
How much does this cost?  
There is no cost to you to participate. Postage 
and disposal costs have been paid through 
support from the Maine Drug Enforcement 
Agency and other in-kind donations from 
program partners.  
Before you begin:  
Gather the unused and/or expired medicine 
you wish to mail for disposal. Leave all 
medicine in its original container(s).  
If you wish, you may use a marker to black out 
your name 
and personal 
information on 
the medicine 
bottle. 
However, 
please do not 
black out the 
name and quantity of the medicine. This helps 
us to identify the medicine for disposal. 
Instructions 
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Please place all medicine you wish to dispose 
of into the postage-paid envelope provided.  
 
Do not put the following items into the 
envelope: 
 
1. DO NOT place loose pills into the envelope. 
Leave all pills in their original bottles. This will 
help us to identify the drug for disposal. If you 
need more than one envelope, please request 
an additional envelope from a participating site 
or call 1-866-637-9743. 
 
The Food and Drug Administration (FDA) requires spe-
cial handling of certain drugs to ensure safe distribution 
and use.  Due to these requirements, some manufac-
turers provide for their own disposal programs.  Please 
check the medicine package or contact your pharma-
cist for more information about manufacturer disposal 
programs that may exist for the medicine you have.  
Please leave medicine in the original      
container(s). Do not black out the name of 
the medicine or the number of pills. 
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2. DO NOT put syringes or sharp objects into 
the envelope. No syringes, sharps, or needles 
or other items that may cause 
injury to the postal carrier or 
program staff are to be placed 
into the postage-paid envelope.  
Even if these items are 
packaged or wrapped, they are 
not to be placed in the envelope. If you would 
like more information about proper disposal of 
sharps, please contact your healthcare provider 
or visit: www.safeneedledisposal.org 
 
3. No batteries, electronics, medical devices 
(hearing aids, blood sugar monitors), or 
thermometers should be placed into the 
envelope. 
No needles, loose pills, pills in baggies, bro-
ken glass, sharp objects, medical devices, or 
thermometers are to go into the envelope. 
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contributing to important research  
⇒ Dispose of your medicine in a way that       
protects Maine’s environment and prevents 
groundwater contamination 
⇒ Get unwanted medicine out of your home and 
away from people who may want to steal your 
medicine or take it illegally 
 
 
  The Safe Medicine Disposal for 
ME Program 
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If you have questions about what to put 
into the envelope, please call the  
 
Program Helpline at: 1-866-ME-RX-RID (1-866-
637-9743).  
Visit our website: www.SafeMedDisposal.com 
E-Mail: info@SafeMedDisposal.com 
 
Find the 5-digit code 
number in the bottom left 
hand corner of your 
envelope.  
 
 
Write it here and  
keep for your records:__ __ __ __ __ 
 
 
 
Complete the survey 
and place it in the 
envelope with your 
medicine.  
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Mailing Your Envelope 
Mail the envelope as you would any other letter 
or package through the U.S. Mail. 
 
There are several choices available to you 
including:  
• Hand the envelope directly to your mail carrier, 
• Bring it directly to your local Post Office for 
mailing,  
• Place the envelope into a blue United States 
Postal Service mailbox at your local Post 
Office or other locations in your area, or 
• Place the envelope in your home mailbox.  
 
 
 
 
 
Thank you for participating in this program! If you 
have any further questions or comments about 
the program please call:  
1-866-637-9743 
 
Please keep this booklet for your records. 
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Program Partners 
The program has been made possible by the 
following organizational partners:  
Please see back page for full listing of program partners 
  
Partners for this program include the:   
♦ University of Maine Center on Aging 
♦ U.S. Environmental Protection Agency 
♦ U.S. Postal Service 
♦ Community Medical Foundation for Patient Safety 
♦ Safe Medicine for Maine 
♦ Maine Department of Environmental Protection 
♦ Maine Drug Enforcement Agency 
♦ U.S. Drug Enforcement Administration 
♦ Rite Aid Pharmacies 
♦ CVS Pharmacies 
♦ Maine Office of Elder Services 
♦ Maine Office of Substance Abuse 
♦ Maine Association of Psychiatric Physicians 
♦ Maine Office of the Attorney General 
♦ Maine Pharmacy Association 
♦ Maine RSVP Programs 
♦ Margaret Chase Smith Policy Center 
♦ Maine Medical Association 
♦ Maine Office of Adult Mental Health 
♦ Miller Drug 
♦ National Council on Patient Information and Education 
♦ Northern New England Poison Center 
♦ Villanova University Center for the Environment 
♦ Maine Department of Health and Human Services 
♦ Maine Council for Child and Adolescent Psychiatry 
♦ Community organizations and pharmacies throughout 
Maine 
Edition: September 2, 2009 
 © 2009 University of Maine Center on Aging  
Instructional photographs: © 2007 Liv Kristin Robinson 
Funded through a Fund for Healthy Maine allocation to the Maine Drug 
Enforcement Agency 
 
 
 
Safe Medicine  
Disposal for ME 
Program  
 
A program for all Maine  
residents! 
 
INSTRUCTION BOOKLET  
 
Information on how to  
prepare and return your 
medicine for proper disposal 
 
Helpline: 1-866-637-9743 
Please Read 
Survey Instructions and Informed Consent 
Safe Medicine Disposal for ME Program 
 
As a Maine resident, you are being given the opportunity to safely and properly dispose 
of your unused medicine at no cost. As a participant taking advantage of this service, 
you are offered the opportunity to tell us more about the medicine you are returning and 
the reason for disposal.  The University of Maine Center on Aging and Safe Medicine 
for Maine has received funds from the Maine Drug Enforcement Agency to offer this 
medicine return program. We will be studying the types of unused medicines Maine 
residents are interested in disposing. 
 
As a medicine return program participant, you are invited to take part in this important 
research currently being done throughout Maine. Information collected from the survey 
provided will also tell us more about the reasons for disposal and the types of medicines 
that are piling up in homes across the state. Research findings will help us to design 
more medicine disposal opportunities for Maine residents and for use nationally.  
 
If you would like to contribute to this research, please take a moment to complete the 
enclosed survey. 
 
What will you be asked to do? 
 
If you decide to participate in the research, you will be asked to complete the enclosed 
survey. It will take approximately 10-15 minutes to complete this survey. Please return 
the survey in the pre-paid envelope provided along with the medicines you are 
returning. You may skip any questions you do not want to answer. 
 
Risks of participating in the survey 
 
Except for your time and inconvenience, participation presents no more risk than you 
would normally experience throughout the course of your day. 
 
Benefits of participating in the survey 
 
There is no immediate benefit to you for taking the survey. 
 
Confidentiality 
 
This survey is anonymous. The information you provide on your survey will be kept 
private. Only the Center on Aging staff and staff from the Maine Drug Enforcement 
Agency (MDEA) will have access to your returned survey.  Please do not write your 
name on your survey. Surveys will be collected from the returned envelopes once they 
are opened for inventory at the MDEA. After the envelopes are opened, all surveys will 
be kept at the Center on Aging for secure storage and reporting. 
 
We will not collect personal information from returned medicine bottles (name, 
physician, etc.). If you wish to black out your name and personal information on the 
medicine bottle, be sure to leave the medicine name and quantity visible. This will help 
us identify the medicine for research and disposal. Information you provide on the 
survey will be linked to information on the type and amount of medicine you returned. 
At the conclusion of the study, medicine and containers will be destroyed. All returned 
medicine will be destroyed in an environmentally friendly way by the Maine Drug 
Enforcement Agency. 
-Please Turn Over-                                          Page 1 
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Any quotes or information used in reports and papers about this research will not 
be linked to your personal information. The survey you provide us will be kept 
indefinitely by the Center on Aging.  
 
Voluntary 
 
Your participation in this research is voluntary. You may choose to participate or not 
participate. You may skip any questions you do not wish to answer. You do not need to 
fill out a survey in order to return medicine. 
 
Along with this information sheet you will find the survey that we are asking you to 
complete. Completing the survey and returning it in the envelope provided along with 
the medicine you are returning will let us know that you want to be a part of this 
research. 
 
Contact Information  
 
If you have questions about the program or how to use the envelope, please call 1-866-
637-9743. 
 
If you have questions about the survey and research you may reach the Project’s 
Principal Investigator, Dr. Lenard Kaye, at 207-262-7922 or len.kaye@umit.maine.edu. 
If you have any questions about your rights as a research participant, please contact 
Gayle Anderson, Assistant to the University of Maine’s Protection of Human Subjects 
Review Board, at 207-581-1498 or e-mail gayle.anderson@umit.maine.edu. 
 
Thank you! 
 
DO NOT write your name (or the name of the person for whom you are returning medicine) 
anywhere on this form. 
Safe Medicine Disposal for ME Program Survey 
 
                                                
 
INSTRUCTIONS: 
 
1. Before completing this survey, please read through the survey instructions 
provided to you with your envelope. 
 
2. This form is for research purposes only. Research findings will help us to design 
more medicine disposal opportunities for Maine residents and create a national 
model. 
 
3. You do not need to complete this survey in order to return your medicines. If you 
choose to take the survey, please return it in the same pre-paid envelope given to 
you to return your medicine. 
  
NOTE: If you need help filling out this form, please call: 1-866-637-9743 
 
Please check the appropriate boxes or write in the spaces provided. You may skip 
any questions you do not want to answer.  
 
 
1.  Have you returned medicine using this mailback program before? 
(Please check (?) one) 
   
? Yes    ? No, this is my first time returning medicine using this program. 
 
Your age: __________years 
 
 
2.  The medicine(s) I am disposing is: (Please check (?) all that apply) 
 
 ? My own medicine 
 ? A relative’s medicine 
 ? A deceased friend or relative’s medicine 
 ? A friend’s medicine 
 ? Pet/Veterinary medicine 
? I don’t know whose medicine it is 
 
 
For the questions below, please tell us about yourself and the medicine you are 
returning. If you are returning medicine for someone else or for more than one 
person, please tell us about the person for whom most of the medicine was 
prescribed. 
 
3. Home zip code: ___________ 
 
4.  Gender:      ? Male       ? Female 
 
5.  Age: _________years    
 
6. Are there any people living in the household in the following age 
 groups? (Please check (?) all that apply) 
    
? Newborn to 10 years  
 ? 11 to 20 years    
 ? 21-64 years           
 ? 65+ years     
     
-Please Turn Over-                                                            Page 1 
DO NOT write your name (or the name of the person for whom you are returning medicine) 
anywhere on this form. 
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7. How did you normally dispose of your unused and unwanted medicine 
 before today? (Please check the method you used most often) 
 
? Flush down the toilet 
? Put in trash 
? Bring to a drug collection event or give to law enforcement officer 
? Don’t know 
? Other:___________________________ 
 
8.  Where did you get these medicines? (Please check (?) all that apply) 
 
? Sample given to me at the doctor’s office 
? Local pharmacy 
? Internet pharmacy 
? Mail order pharmacy  
? Given to me by a friend or family member  
? Other (please list):___________________________ 
 
9.  Why do you want to get rid of these medicines? (Please check (?) all 
 that apply) 
 
? Doctor told me to stop taking the medicine(s) 
? Doctor gave me new medicine(s) to take instead 
? I had a reaction or allergy to the medicine(s) 
? I did not like the side effects 
? I did not want to take it 
? I got better/did not need it any more 
? I don’t want anyone else to use them 
? Other (please list):_______________________________________ 
? I don’t know/I don’t remember 
 
10.  What is the most important reason behind your decision to use this 
 program? 
Please place only one check by the most important reason to you. 
 
a) Best for the environment  ___ 
b) Safest for me and my family ___  
c) Other: __________________________________________ ___ 
 
11.  How important are the following features of this program? 
Please rank from 1-3 with 1 being the most important and 3 being the least 
important.  
 
a) Convenient to use   ___  
b) Free to use    ___  
c) Anonymous    ___ 
d) Other: __________________________________________ ___ 
 
12.  How useful is this medicine mail-back disposal program to you? (please 
 circle) 
 
Very useful  Useful Somewhat useful  Not useful 
 
13.  What can we do to improve this program? (please write in) 
 
 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
When complete, please fold the survey and place it into the envelope along with the 
medicines you are mailing back. For more information about the Safe Medicine Disposal 
for ME Program please visit: www.safemeddisposal.com, e-mail: 
info@safemeddisposal.com or call 1-866-ME-RX-RID (1-866-637-9743). Thank you. 
APPENDIX GROUP 8 
Consumer and Community Education Items 
 
• APPENDIX GROUP 8:  Consumer and Community Education Presentation 
Materials 
 
o APPENDIX 8A: Sign-in sheet for community presentations 
 
o APPENDIX 8B: PowerPoint presentation  
 
o APPENDIX 8C: Program information handout 
 
o APPENDIX 8D: Community presentation evaluation form 
  
o APPENDIX 8E: Guidelines for community volunteers 
 
o APPENDIX 8F: Self-report timesheet for community volunteers 
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Safe Medicine Disposal for ME: 
Funded by the U.S. EPA  Aging Initiative 
 
 
Program goals: 
• Remove unneeded prescription drugs from circulation by providing an 
environmentally safe way to dispose of medications. 
 
Environmental impact of pharmaceuticals:  
• Studies are revealing negative environmental impacts on water quality and aquatic life from 
flushed medications.  
 
Facts about Teens and Rx Abuse: 
• Many teens believe that prescription drugs are safer than alcohol or illicit drugs, and that 
abusing them isn’t risky.  
• “Pharm Parties” are where teens dump bottles of prescription medications into a punch bowl 
and ingest random medications to get “high”. 
 
Medication Safety: 
• Some poisonings reported to poison control centers come from the accidental ingestion of 
medications that have been left unsupervised and within the reach of children. 
• Home burglaries related to prescription drugs are on the rise.  
 
Remember to: 
• Review the contents of your medication cabinet regularly.  
• Check the expiration dates on your prescription and nonprescription medications. 
• Store medications safely, out of the reach of children and in a locked cabinet if possible. 
 
How you can safely dispose of medications: 
• Utilize the Safe Medicine Disposal for ME program. Call the program helpline at  
      1-866-637-9743 for more information. Or email: info@safemeddisposal.com.  
• Contact your local law enforcement office to see if they sponsor a medication take-back 
event or drug drop-off day in your community. 
• Contact the Northern New England Poison Control Center at 1-800-222-1222 for other safe 
disposal options and to add medication take-back event dates to their 
informational calendar. 
 
   Information gathered with thanks from: 
   National Council for Patient Information and Education 
   U.S. Environmental Protection Agency 
   Northern New England Poison Control Center 
   Maine Department of Environmental Protection 
   Maine Office of  Substance Abuse Services                 
   Maine Benzodiazepine Study Group 
   Project  AWARE 
 
Safe Medicine Disposal for ME Community Education 
Presentation 
 
Instructions: This survey form was developed to find out levels of awareness that the general public has 
of prescription medication issues.  Each audience member can complete the questionnaire.   The 
information collected by the evaluation helps to improve these types of community education programs. 
 
1. Today’s Date: _____/______/_________ (MO/DD/YYYY) 
 
2. What county was this presentation provided in?: (please fill in the blank below) 
__________________________________________________________________ 
 
3. Your Age: 
 _____19 or under  _____20-29  _____30-39  _____40-49 
 _____50-59   _____60-69  _____70-79  _____80 and over 
 
4. Your gender:    _____Male  _____Female 
 
5. Have you ever participated in a community take back/drug drop off program to dispose of unwanted 
medications?        (Please circle one)         YES    NO 
 
6. Overall, how would you rate this presentation: (circle one) 
Needs Improvement  OK   Good   Excellent 
 
7. Comments:____________________________________________________________________ 
 
Respond to each of the following statements below by circling either TRUE or FALSE in the box next to 
the statement. 
1. It is important to discard any unused or 
expired medications in my home.   TRUE         FALSE 
2. It is important to discuss the dangers of 
prescription medications with family 
members. 
 TRUE         FALSE 
3. Proper disposal of medications protects the 
environment and keeps people safe.   TRUE         FALSE 
4. Prescription painkillers are not addictive 
because doctors prescribe them.   TRUE         FALSE 
5. Prescription drug abuse is not a problem in 
Maine. 
 TRUE         FALSE 
6. Many teens believe that prescription drugs 
are safer than alcohol or illicit drugs, and 
that abusing them is not risky.  
 TRUE         FALSE 
7. Flushing medications does not harm the 
environment.   TRUE         FALSE 
8. Medicine has an expiration date similar to 
food that you should pay attention to.  TRUE         FALSE 
Thank you!  Please give this sheet to your presenter before you leave. 
Presentation Guidelines for “Safe Medicine Disposal for ME” Volunteer 
Community Education Presentations 
 
Setting up a speaking event: 
1. Arrange speaking opportunity with a community group – inform Jen
about date, time, place, and audience size 
2. Ideal audience size is 10-15 people 
3. Plan on a total meeting time of 30 minutes (allowing time for discussion) 
4. Use a round-table approach if possible 
5. Distribute the handouts/pamphlets to audience members before you start 
6. Go through the presentation slides with the audience – demonstrate the 
use of the envelopes at the end of the presentation 
7. Have audience members fill out an evaluation form and pass them in to 
you before they leave – in exchange they will receive an envelope 
8. If possible, take pictures at the event 
 
Materials checklist: 
1. Copy of the presentation for you to speak from 
2. Sign-in sheet 
3. Educational pamphlets/handouts 
4. Evaluation forms 
5. Drug return envelopes 
6. Pens 
7. Camera (you supply) 
8. “Safe Medicine Disposal for ME” name badge (previously given) 
 
Presentation flow: 
1. Introduce yourself as a “Safe Medicine Disposal for ME” volunteer 
2. Have the audience members fill out the sign-in sheet  
3. Inform audience members that your goal is to provide them with 
information about medication safety and the “Safe Medicine Disposal for 
ME” program 
4. Distribute educational materials and the evaluation form to the audience 
and begin the presentation by following the presentation outline 
5. At the end, demonstrate how to use the drug return envelopes 
6. Have audience members fill out evaluation forms and in exchange for a 
completed evaluation they will receive an envelope 
7. Thank them for their participation 
 RSVP 
 
Safe Medicine Disposal for ME Program 
 
RSVP VOLUNTEER HOURS 
Self-Reporting Timesheet 
COMMUNITY VOLUNTEERS 
 
Name  _________________________________________________________      
Address  _________________________________________________________ 
           _________________________________________________________ 
  
To be completed by the RSVP Volunteer: 
                       
 Volunteer Activity/Location    Hours  Date 
 
__________________________________________      ____________     __________ 
__________________________________________      ____________     __________ 
__________________________________________      ____________     __________ 
__________________________________________      ____________      __________ 
__________________________________________      ____________      __________ 
__________________________________________      ____________      __________ 
__________________________________________      ____________      __________ 
__________________________________________      ____________      __________ 
__________________________________________      ____________      __________ 
         Total 
          Hours     ____________  
Volunteer Signature ________________________________________________ 
Signature of On-Site Contact Person____________________________________ 
 
Please return at the end of the month to: 
 
UMaine Center on Aging  
RSVP 
Camden Hall 
25 Texas Avenue 
Bangor, Maine 04401-4324 
APPENDIX GROUP 9 
Marketing & Outreach Items 
 
• APPENDIX GROUP 9: Marketing and Outreach Materials 
 
o APPENDIX 9A: Consumer fact sheet 
 
o APPENDIX 9B: Detailed fact sheet 
 
o APPENDIX 9C: Program brochure 
 
o APPENDIX 9D: Program summary sheet 
 
o APPENDIX 9E: Program business cards 
 
o APPENDIX 9F: April 2007 program press release 
 
o APPENDIX 9G: July 2009 program press release 
 
o APPENDIX 9H: Sample press release for local communities 
 
o APPENDIX 9I: Save the date announcement for the 2008 
International Symposium on Pharmaceuticals in the Home and 
Environment  
 
o APPENDIX 9J: Save the date announcement for the 2009 
International Conference on Safe Medicine 
 
o APPENDIX 9K: List of program-related publications and 
presentations 
 
Safe Medicine Disposal for ME: A Handbook  ? March 2010 A9 
 
Safe Medicine Disposal for ME Program 
 
Do you have unwanted or expired 
prescription medicine in your home? 
 
Many people do not use all of the medicine they were 
prescribed. It is important to get rid of your unwanted or expired 
medicine safely. 
 
This can help prevent: 
• Accidental poisoning of children, grandchildren, and pets 
• Intentional misuse by teenagers and adults-even people you know 
• Health problems from taking the wrong medicine, too much of the same 
medicine, or a medicine that is too old to work well 
• Theft of the medicine by drug users who may break into your home 
 
You can get rid of your unwanted or expired medicine in a 
way that keeps people safe and helps keep leftover 
prescription medicine from getting into Maine’s water supply 
and environment. 
 
 
Some options include: 
• A medicine disposal program by mail, like Safe Medicine Disposal for ME. This 
program provides Maine residents of all ages with a special envelope to mail 
unwanted or expired prescription medicine for safe disposal.  
 
• A community medicine drop-off event. You can find out if 
there is a program in your area by contacting Northern 
New England Poison Center at 1-800-222-1222. You can 
also call them to get help identifying your medicine or for 
medicine-related concerns.                                      
            
• Talking to your pharmacist or local law enforcement about other safe options 
For more information about safe medicine disposal, contact:  
Safe Medicine Disposal for ME  
1-866-ME-RX-RID 
 (1-866-637-9743) 
         info@safemeddisposal.com                    
www.safemeddisposal.com       
  
CONSUMER FACT SHEET 
Safe Medicine Disposal for ME Program 
 
Based on figures from the National Unused and Expired Medicine Registry, as many 
as 40% of prescription medicines are never used. Such medicines represent an 
expensive waste of healthcare resources and a potential environmental and safety 
hazard.  
 
Unused Prescription Medicine is: 
An Environmental and Health Hazard 
• Over half of Americans dispose of unwanted prescription medicine in the trash, one-third put it down 
the sink or toilet, and only 1.4% return it to a collection facility.1 
• Prescription medicine then enters the water through disposal down a drain or from the leaching or 
leaking of the drugs from landfills.2 
• Over 80 pharmaceuticals of various prescription drug classes have been found in treated sewage, 
surface water, and ground water throughout the country.3 
• Studies have found that exposure to medicine in water has been linked to serious reproductive side 
effects in fish, and the full effect on humans is currently unknown.4 
 
A Danger to Children and Pets 
• Children and pets can accidentally get poisoned by unused prescription medicine found in the home. 
• In the US, medicine in the home accounts for more accidental poisonings than any other product.5 
• Nearly 2% of children ages 12-13 intentionally misuse prescription medicine.6  Accessibility to the 
medicine is likely a contributing factor to this growing trend.7 
 
A Danger to Older Adults 
• Older adults make up only 13% of the population, but fill one-third of all prescriptions. This makes 
them susceptible to intentional or accidental medicine misuse, dependence, and addiction.8 
• Diversion and theft of prescription medicine is currently at very high levels, and older adults may be 
particularly at risk.9 
 
A Danger to Communities 
• In 2002 in Maine, almost 90% of all drug deaths were caused by prescription medicine.10 
• The non-medical use of prescription medicine, among US residents ages 12 and older, is more 
common than the use of any illicit drug except marijuana.11 
• Maine DEA arrests for prescription medicine misuse have increased dramatically to 16% of all 
arrests.12 
 
A Waste of Valuable Healthcare Dollars 
• One small study conservatively estimates the cost of wasted prescription medicine by adults ages 65 
and older to be over one billion dollars annually. 13 
• With healthcare costs rising at 3 times the rate of inflation, this waste will only continue to grow.14  
 
For more information contact Safe Medicine Disposal for ME  
1-866-637-9743  
DETAILED FACT SHEET 
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The University of Maine Center on Aging has received funding through a Fund for Healthy Maine 
allocation from the Maine Drug Enforcement Agency to operate Maine’s prescription drug-return-by-mail 
program, the first of its kind in the country.  
 
Program Take-Back Model at a glance: 
                                                                                                                                        
 
                                                          
→                                                          →                                                                                         
 
  
 
 
 
 
 
Why Maine?  
 
 Maine has the oldest population in the nation as measured by median age. Americans age 65 and older 
account for over one-third of all prescription drugs dispensed, despite making up only about 13% of 
the national population.  
 
 The state of Maine has previously experienced and documented the consequences of unused drugs 
remaining in circulation. In 2002, nearly 90% of all drug deaths in Maine were caused by prescription 
drugs. Maine DEA arrests for prescription drug theft and misuse have increased dramatically to 16% 
of all arrests in the state. Maine ranks number one in the country in terms of the relationship of 
pharmaceuticals to violent crime and property crime.   
 
What are the benefits of this model?  
 
Many other areas of the country are considering replicating our model of drug disposal. Here’s why:  
 
 Avoids the harmful environmental impacts and health hazards of flushing or disposing of drugs via 
household trash  
 
 Easy, convenient, and anonymous way of disposing of drugs  
 
 Takes advantage of the security protocols of the U.S. Postal Service mail system  
 
 Accessible to those who live in rural areas and are unable to attend event-based or on-site medicine 
return programs 
 
Safe Medicine Disposal for ME Program 
 
 
 
 
 
 
 
 
 
Kits distributed to Maine 
residents through 
designated pharmacy and 
community sites free of 
charge 
                                
Unused medications                  
returned by mail to a 
centralized Maine Drug 
Enforcement Agency 
location 
 
 
Medication returns 
cataloged by program 
pharmacists and then 
destroyed by 
incineration 
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 Drugs are returned directly to the Maine Drug Enforcement Agency so the program is able to accept 
controlled substances  
 
 From a social standpoint such a program presents the opportunity to: limit drug related crimes, limit 
opportunities for drug abuse, and reduce waste related to medical and insurance costs by providing a 
safe alternative from stockpiling medications in consumer’s homes 
 
 The potential environmental benefits include: protecting water and soil supplies from drug 
contamination and prevention of accidental poisonings of humans, pets, and wildlife   
 
This initiative is a unique collaboration between environmental, drug enforcement, and healthcare 
officials and puts the University of Maine in the forefront of innovative outreach research.  Lessons 
learned through this program can be used to shape state and national public policy, physician prescribing 
practices, and health education outreach strategies. 
 
Program Partners: 
Program partners include the: University of Maine Center on Aging, United States Environmental 
Protection Agency, United States Postal Service, Community Medical Foundation for Patient Safety, Safe 
Medicine for Maine, Maine Department of Environmental Protection, Maine Drug Enforcement Agency, 
U.S. Drug Enforcement Administration, Rite Aid Pharmacies, Maine Office of Elder Services, Maine 
Office of Substance Abuse, Maine Association of Psychiatric Physicians, Maine Office of the Attorney 
General, Maine Pharmacy Association, Maine RSVP Programs, Margaret Chase Smith Policy Center, 
National Council on Patient Information and Education, Miller Drug, Maine Department of Health and 
Human Services, CVS Pharmacies, Maine Office of Adult Mental Health Services, Maine Medical 
Association, Northern New England Poison Center, Villanova University Center for the Environment, 
Maine Council for Child and Adolescent Psychiatry, University of New England and community 
organizations and pharmacies throughout Maine. 
 
Program Contacts:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Website:  www.safemeddisposal.com 
E-Mail: info@safemeddiposal.com  
Phone: 1-866-637-9743 
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Rx Drug Mail Back Program Comes to Your Community! 
Ever wondered how to dispose of expired or unused prescription medicine?  Now, 
thanks to the Safe Medicine Disposal for ME Program, disposing of prescription 
medicine has never been safer or easier. The program provides postage-paid mailing kits 
to participating pharmacies in the area.  Patrons can pick up these kits and then mail their 
unused medicine to the Maine Drug Enforcement Agency for proper disposal.  
The Safe Medicine Disposal for ME Program, funded by the Environmental 
Protection Agency and other state partners, helps to ensure that unused medicine does not 
harm Maine’s waterways or wildlife and also ensures that medicine is not available for 
misuse.   
This free program is available at the following COUNTY NAME HERE locations 
and is open to all Maine residents: 
 
LIST SITES HERE 
Simply go to one of the pharmacies on this list to get your mail back kit.  Each kit comes 
with instructions and postage paid mailer.  If you would like more information please 
contact the program by phone or email at 1-866-637-9743, info@safemeddisposal.com or 
online at www.safemeddisposal.com 
 
 
 
www.mainebenzo.org 
Continuing Education Details: 
The 2008 International Symposium on 
Pharmaceuticals in the Home and 
Environment:  Catalysts for Change  
The University of New England is accredited by the American Osteopathic 
Association and the Maine Medical Association to provide continuing medical 
education for physicians.  
• UNE designates this educational activity for a maximum of 11.0 Category 
        2A osteopathic, and 11.5 AMA PRA Category 1 CreditsTM. 
• Approved for 11.5 University contact hours (1.2 CEUs) by the University of 
New England. 
• CEUs pending for Maine Boards of Pharmacy and Social Work Licensure 
• Certificates of attendance will be provided 
Telephone:  207.262.7928 
jason.charland@umit.maine.edu 
For Conference Information Contact: 
Jason Charland, Conference Coordinator 
UMaine Center on Aging 
Register online at: 
www.mainebenzo.org 
Monday-Tuesday 
November 10-11, 2008 
Wyndham Hotel Portland Airport 
South Portland, ME 
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This year's conference will be the gathering place for disseminating the latest trend 
data available on prescription issues including: 
 
* Drug diversion, fraud, prevention, and abuse 
* Innovative national and international prescription drug return and 
disposal programs 
* Medication management and prescribing 
* And much, much more! 
Conference Sponsors: 
 
 
Registration fees  
2 days $199 (students = $150) 
1 day   $119 (students = $75) 
 
Wyndham Hotel Portland Airport 
363 Maine Mall Road 
South Portland, ME 04106 
 
1-800-996-3426 (1-800-WYNDHAM) 
 
Group Code: UMaine Center on Aging 
Group Room Rate: $94. + tax 
 
 Get your Continuing Education Credits before 2008 ends!   
www.mainebenzo.org 
 2009 International Conference 
on Safe Medicine  
Point Lookout Resort and Conference Center 
Northport, Maine 
 
Sunday-Tuesday 
October 18-20, 2009 
SAVE THE DATE! 
• Meet with the leading authorities on prescription drug use,  
 abuse, return and disposal 
• Attend cutting edge educational symposia and panel 
sessions  
• Build your skills at expert-led, pre-conference, technical 
assistance workshops  
• Participate in lively specialized topic interest groups 
• Enjoy the special networking opportunities, exhibits, and  
 annual film festival 
Call for proposals, films, and exhibitors coming soon! 
For more information contact: 
Maine Benzodiazepine Study 
Group 
& Drug Disposal Group 
UMaine Center on Aging 
Phone:  207-262-7922 
Email:  mbsg@mainebenzo.org 
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